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ABSTRACT
The e ffects of ad re nerg i c drug s on t he d e velop men t o f
male -spec ific cytochrome P450 i n t he male ra t liver were
stud i ed. Pups , ca strated o n Day 0 , we r e given (icv) a-
a n tagon i s t or a - ag on i s t wi t h or without testosterone
propiona te (sc.), en d assayed on Day 65 . Ot he r pups were
admin i s tered wi th (icv ) adrenergic ac;on ists or antagonis t s on
Day I) & 3 of li f e , castrat ed on Day 55 , and assayed on Da y 70.
Neithe r a-ant agonist nor B-agonist de fem inized the EHDM
activity i n ne onatally castr ated ra ts . In the rats castrated
on Da y 55 , a - anta g oni s t and a I -antagonist superdefemin i zed the
EMOM ac t ivity . a - antagonist in c reased the total amount of
P450 but ai-antagonist did not. I n addition, the Vmax o f EMDM
in O-antagonist-treated animals was increased ; t he KIn was
unchanged. Fur t her , J3-antagon i s t stimulated the act ivities of
160-, 2a-, and 60 -testosterone hydroxylases in the
superdefeminized rats.
antagonist, given
Howeve r, both B-antagonist a nd QI-
s imul taneously, s upp r e s s ed t he
su perdefeminization of EMDM activity.
The e ffec t of monos o d i um glutamate (MSG) on the
prepubertal deve lopment of male-specific cytochrome P450 i n
rat live r wer e also s tud ied . Pups were treated on Day 1-9
with 2 or 4 mg/q MSG tec j , and on Day 35 the EMDM ac tiviti e s
iii
in 2 and 4 mg/g MSG-treated groups were the same as control
va l u e s . However , MSG s t imulated, dose-dependently , the EMDM
act ivity o n Day 65. In addition, Vmax of EMDM was elevated in
MSG-treated group; the KIn was unchanged. Fi nal ly, 01 mg/ g MSG
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F igure
Cyto c h r ome P45 0 catalytic cycle
1.0 INTRODUCTION
Cy tochromes P450 are a superfamily of heme proteins .
These cy t c ch r cme s are found ma inly in the liver , but they a lso
occur i n othe r t i s s ue s , such as lunq, k idney , intestine, skin,
testis, placenta , and adrena l (S i pes and Gando llfi, 1991).
These proteins are parts of a system t ha t oxidizes s tero ids ,
vitamins, f a t t y acids and many x.e nob i o t i cs such as d r ugs ,
pe s t i cides . The cytochromes P450 are the termina l oxidase and
s ubs t rate binding en zymes in some 30 different monooxygenase
reactions th a t i nclude aliphatic hydroxylation , a romatic
h yd r oxy l a t i on , de a min a t i on , and N-hydroxylation , etc . (Sipes
and Gandollfi , 199 1) .
The cytochrome P450 catal yti c cycle is presented in
Figure 1 : the xenobiot ic combines wi th the o xidized form of
c ytochrome P45 0 (Fe].) to form a su bstrate-cytochrome P450
complex . This co mplex accepts an e lectron from NADPH via
NADPH-cytochrome c reductase, which r edu ce s t he i ron i n the
cytochrome P450 heme to t he Fe!' state. The reduced complex
t hen combines with one molecule of oxygen, which accepts
another electron from NADP. This molecu lar o xy ge n r ad ica l is
h i gh l y reacti ve and unstable a nd one atom of it i s introduced
i n t o the s ubstrate , wh ile the other is reduced to water . The n
t he oxygenated su bstrate dissociates, regenerating t he
o xidized form of c yt oc hr ome P450 .
Dor UH
a .y'P.45C(F,")"<
(RH)P ~450(Fc~ 'J )J + (RH)P-4 50(Fc'J+)
HOH~I yc:
(P.H)P· 450(Fe3 +) (HO:!- ) (RH)P-450(Fe:l +)
\ f a,
(RH)P .4 50(Fc")(0,' -) (RH)P.4 50(Fc" )(O,)
e -~
Figure 1. Cytochrome P450Catalytic Cycle
(modifiedfrom:Robert AN(1980). "Metabolismof toxic
substances." In: Casarett andOoull's Toxicology, the Basic
Science oCPoisons,2nd ed. edited by Doull J, Klaassen CD,
andAmdurMO,MacmillanPublishingCo., Inc. New York]
The a ct: i v i t y of cytochrome P4 S0 mediat e d r e a c tions c a n be
i n fl ue nc ed by factors such as diet ( Ande r son and Ka p pas,
1991l, hormones ( Lun d et al ., 19 91 l, pe ptid e s (Ur b an e t a l. ,
1990 ), ch emicals ( Bo ck e t aI. , 19 90 ) , s e x (Kato, 19 7 H. and
age (Wa xman et al. , 1985) . Al terations i n the act i v i ty of
c y toch r ome P45 0 will i nf l ue nc e the normal physiologica l
metabol ism and t he me tabolism of drugs and other xenobiotic s ;
whi ch may i nterfere with t he normal physiologica l func t ion s i n
the bo dy and induce pathogene s i s . Therefor e , stud i e s on
cyt ochrome P450 a re imp ortant in toxi co l o gy . This thesi s i s
an attempt to exami ne the ro l e o f ne onata l cldrenerg i c
rec epto r s i n the centra l nervou s system in the de fem i n iza t i on
of he pati c male-specific cytocbromes P4 50, an d the r o l e Clf
q row t h hormo ne (G H ) in t he p repub ert al deve lopment of hepatic
cytochrome P450 i n male r a t s .
1 .1 HEPATIC CYTOCHROME AND BRAIN SEXUAL DI FFERENTI ATION
1.1.1 Suua l Diff erences o f Hepatic Cytochrome P45 0
Oxi dations
Ox i da t ion of a numb e r o f xenobioti c s a nd s t e r o i ds 1n t he
adu l t rat liver i s sex specific . Fo r e xa mp le , female rat s
given hexoba r b i t al s leep longer than ma l e s (Ho lck et a1.,
1937 ) and s imi lar results had also been shown by othe r authors
(Quinn e t; al ., 195 8 ) . Microsomes from the l i ver o f adult male
rats ox idize ethylmorphine and benzo(a )py rene more rap idly
than do those from t h e fema les ( Chu n g et a1., 19 75 : Davies et
a l., 1969; Gurtoo and Pa rker , 197 6 ; Hietanen, 19 74), a nd
although mf c z-cscmea from t he livers o f a d ult male rats h a ve
10 %- 30 % more cytochrome P450 than those f !"om females (Chung ,
1977 ; Colby, 1980 ), this d i f f e r ence does not accoun t f o r the
d i f f e r e n c e s in t h e rates of metabolism of t hese x e no b i o t i c s
( Kamataki et al . , 1980; xecc , 197 4). Moreover , other studies
(Kato and Kamatak i , 1982 : Kama taki et a1., 1982; Mac Geoch e t
al . , 1984; Morgan et a l. , 1985) showed that isoforms of
hep a ti c cytochromes P450 were sexu a lly d i f f ere n t i a t e d in adult
r a t s and that the e x istence of t hese sex -specifi c isoforms,
s u ch as cytochrome P450 2Cn, 2C12 , o r 3Al /2, l eads to the
sexual differences i n t h e s ubstr a te me t a bo li s m.
1 .1 . 2 Sexual Di f ferences o f Cytochrollle P45 0 and Neonatal
Androgen
Th e s e sex ual ly d iffe rent a c tivi t ies of c ytochrome P 450-
c a ta l yzed oxidations are the res u l t of ne onata l and pubertal
exposure o f the r a t to androgen . Castration of ma le rats in
the neonata l per iod decreases ethy l morphine N-demethylation ,
propoxy coumar in O- deprop y l a tion an d benzo (a )p yre n e
h yd roxyl a tion to t he f ema l e level (S himada e t a l. , 1987 ) ;
neonata l admini stration o f cas ':;ra ted lllale pups wi th
t e s tosteron e in c reased the a ctivit i es of the enzyme s but not
up to the lev e ls of t he normal adul t mal e s . However, others
found t hat t he ac tivity o f ethylmo r ph i ne de methy l a s e ( EMDM ) i n
neonata l cas t r a t ed mal e rat s , trea t ed ne .>natally a nd i n
adul thood with testo sterone , was t he same as that i n i n t a ct
males ( Re yes and Vi rgo, 1988) . The male isoforms of
cytochromes P450 i n adult mal e rats cas t rated ne on a t a lly a re
ba r e ly de t ec tabl e while t he fema l e - s pec ifi c isoforms appea red
a t a l e ve l compa r a b l e to those f ound i n adu l t f e males
(Kamataki et a I. , 1983, 1984; Kato and Kamataki. , 1982 ; Waxman
et aI., 1985; J an s s on et aI., 198 5al . Moreover, the
administrllt ion t o these animal s of neona tal and postpuberta l
test osterone ca use d the appearance of male- type cytoc:hro mes
P450 and t he disappearance o f the fellla le types (Sh i mada et
a l ., 1987) . It appears t ha t the sexually d i fferent cyt oc h ro me
P45 0 en zymes a r e the resul t s of neonatal and post-pUberta l
e x p o s ur e o f t he r a t t o androgen .
Sexual differentiation of cytochrome P450 e nzyme is
bel ieved t o resu l t from t wo dis t inct androge n- d e pe ndent
processes: i ) de femi nization, which suppresses f e mal e
characteristics , permitting ma le ch aracte r istics to de ve l op ,
and during t he neona tal p e r i od, an d i i )
masculini zation , which enhances t he mal e characteristics i n
adul t hood ( Re yes & Virgo, 1988) . Furthermore , d e femin ization
is t hought to be a ne ces s ary prerequi si t e for t he
masculin ization (MacLusky and Naftolin, 1981 ). Neona tal
castration comple te l y a nd i r r ever s i b ly de p resses the
e c 't r v t t t es of e thylmor phine deme thylase i n adu lt mal es , bu t
t he e n zyme activ i ti es c an be p e r mane n tly inc r ea sed , al beit no t
t o the l e ve l s i n intact adul t males , if t hese a nimal s a r e
g i v e n testos te ro ne immedi ately a fte r cas t rat ion ( Virgo , 1 991 ) .
Adul t castration, ho weve r , dec rease s t he e nz yme activit ies to
the d efe mi n ized l ev els , wh i ch can be mas c ulinized by
testosterone . Thus, the s e data show t ha t neonatal a n drogen
permanently defeminizes the e nz yme system, a nd p uberta l
androgen mas cu lin i zes the de fe minized enzyme s bu t not
permanently . Howe ver , ne onata l e xposu r e o f t he r a t to
androgen is not a n esse nti a l pr e requisite f or t he s e xua l
d ifferenti ati on of drug met a bolism. Bot h Shi mada (19 87) a nd
Vi rgo (1991) ha ve reported tha t mas c ulin ization c a n occu r i n
the a b s e nce of d efemi nizat ion . For e xa mp le, neo nata l
ca s tration co mp l e t e ly supp ressed t he acti v i ties o f the hepati c
enzymes i n adu lt ma l e rats , bu t t he l evels o f ethy l morp h ine N-
d e methy l a tion (Shima.da e t al ., 198 7 : Vi r go, 199 1) ,
hydroxylation (Sh i mada et a l . , 1987)
propoxycoumarin O-depropylat ion and ben ac t a j pyr en e
increased to the
leve ls of i n t act adult male r a t s by p e r i pu b e r t a l testosterone
trea t ment. These data suggest that neonata l androgen i s not
necessa r y for the e ffe c ts of pubertal androgen though i t can
pe r manently defeminiz e the enz yme system . However , older
ad ult male rats (Day 75 -8 0) castrated ne onata lly d o no t
respond t o testosterone (Virgo , 199 1) , end f emal e rats a lso do
no t r e sp ond to either neona ta l or ad ult testosterone ; the
reasons for t hes e phenome na are not yet known .
1 .1 .3 Sex Di fferenCl;Is o f Hepa tic Cytochrome Oxi da t i on s and
the Secretory Pattern of Gr owt h Hormo ne
1 t wa s pos t u lated origina lly t hat t he f emale pi t u i tary
s ecre t es a h or mon e , " f e minotr opin", that fem i n i z e s t he female
c yt ochrome P450 s ystem (Gusta fsson et al. , 1977), and t hat
" f e mi n o t r op i n " releas e is blocked in t he ma l e b y a
hypo t halamic hormone, " feminostatin" (Gusta fsson e t al., 1 976 ;
Gustafsson et a l ., 1977) . By investigating diffe re nt
p itu i t ary hormones , i t wa s found that on l y growth ho r mone has
manifes t ef f ects o n the sex-depe ndent cyto chromes P4 50 in the
rat l i v e r ( Gus tafsson e t a1. , 1983 ) . Moreover, growth ho rmone
wa s found to play t he r o l e of " femi n otropin". Fo r examp le ,
exogenous GH feminhes the act ivities of cytochrome P450
s yste m of intact, castrated , and hypophysectomized males
(Kramer et a l ., 1975; Mod e et al . , 19B1). Agents such a s
so matostati n (Virgo, 19B5 ) that block GH-rele ase wi l l
masculinize th e cytochrome P45 0 s ystem o f cas t r a t ed males
while a gent s su ch as c lo nidine (Virgo, 1985 ) that s t Imut e t,o GH
rel e a se wil l f e mi nize the cytochrome f'450 system of intact
males . Al l these obse rv ations s uggest tha t GH plays the role
of "fe mi notropin" .
Howeve r , GH ex i s t s 1n both males and females . If it is
t he fac t o r t hat fem i ni zes t he cytochrome P4 S0 system, the r e
s hou l d be some d iffe r ences in GH bet ween t he males a nd t he
f ema l es. The c urren t data i ndicates t ha t t he secretory
patte r n s o f GH are s exua lly different. Male rats exh i bit very
l ow nad i r leve l s o f p lasma GH with ma r ked peaks ever y 3 - 4 h .
Female r a t s , in contras t, have a h i ghe r ba sal GH leve l a nd
more irregu lar pea ks of small er amplitude ( J a ns s on at a l . ,
19B5b ). It appears that it i s t h is sexua l dimorphism tha t
determines the activ i ti es o f hepat i c cytoc h ro me P4S0 med iated
ox i da tions . Cytoch ro me P450 2ell is a male -speci fic isoform
an d ex i s t s i n hi gh l e vel s in i n t act adult males but low l e ve ls
in i n tact femal e s . Cyt oc hrom e 2C12, a ov e v e r , is a f ema l e-
s p ec i fi<: isoform and ap pe a rs in a hi gh concentration i n i ntact
female adults but low in intact adult males (Mode et aI.,
1989; waxmen et al ., 1985 ). Hypophysectomy decreases the
levels of both i s o f o r ms in adult rats . However, intermittent
administration of GH, mimi ck ing the male secretory pattern,
caused comp lete masculinization of the male specific P4S0 2en
in hyp o phy s ec t omi z e d males ; when GH was administe red
continuously, mimicking the fe ma l e secretory pa t t e r n , the
female s pe c if i c P4 S0 2C12 was i nduc ed i n the hypophysectomized
f emales (Mode et a l. , 19 89; Legrav erend e t al. , 199 2 ). Th e s e
da ta sugges t t ha t some isoforms of s ex-de p e nde n t P4 S0 a r e
related to the s exua l dim orphism of GH sec r e t ory pattern .
This sexual dimorphism of GH secretion is t he resul t of
e xposure o f male rats to androgen during the neonatal per iod
and adulthood (Jansson an d Frohman, 1987) . Ne ona t a l
cas t ration caus e s a marked su p pression in bo t h the IDaqnitude
a nd the du ration o f GH s ecretion , an d higher b a seline GH
l e ve ls than that in eheei-opereued controls , i e . f e llli n i ne
charac t e ristics o f GH secret ion . Al though ne ona t al
t e stos t e r o ne replacemen t therapy r e stored h igh amp litude GH
p ul s e s , t hey occurred mo re fre qu e ntly an d t he ba s e line GH
levels were ma r kedly hi g he r t han t hos e i n i n t act male ...acs .
However, ne onatall y c a s t r a ted rat s given testosterone
neonatally and a lso d ur i ng adulthood displayed a no r mal GH
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pat t ern co mparabl e to that of intact males ( J a n s son and
Fro hman . 1987) . Th e r efor e . neonata l androgen c a n permanent ly
defeminize the secreto ry patte r n of GH, and androgen i n
adul thood c a n mas c u lin i ze the defeminized GH secre tion.
Howev e r , a mas culine GH pattern was a lso seen in t he
neon atally c a s t rate d male rats g iven tes t os te rone o n l y during
adul thood ( J a n s son and Frohman , 19 87) . Thu s , de fem i nization
is not an e ssentia l prerequisi te f or mascu lin izat i on .
concurrently, neonatal c a s t r a t ion comp le t ely supp resses EMDM
a ctivi t ies in adult males, and neonatal t esto s t eron e
r e pla c eme n t partial ly restores the act ivity; but both neonatal
and adult t e s t o s t e r o n e comp l e t e l y restores the enzyme activity
(Virgo, 1991) . Furt her, peripubertal testosterone can i nduce
an i nta ct adult level o f en ayme a ctiv i ty in adu l t males
castrated neonatal ly (Vi r go , 199 1 ) • Thus, t h e sexua l
different iation of this enzyme system is parallel t o that of
GH s ecretory pattern .
1.1.4 Hypothalamic Regulat ion of GH Secretion
GH secret ion is under the cont rol of the hypothalamus .
The hypothalamus p r oduces GH- r ele asin g hormone (GHRH) which
stimulates the synthesis and r e l e a s e of GH, and somatos t atin
(55 ) whi ch i n h i bits t h e synthesis and release of the ho rmone
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(Jansson a t a1 . , 1985 b). It has been reported (Painson et
a l ., 1991 ) that the secret ion of GHRH shows episodic pu lses,
and that andr ogen c a n increase the ampli tude of the GHRH
pulses. Male rats also display a periodic 55 secretion with
peaks at the t ime of the t r ou gh o f GHRH secretion, and GH has
a p o s i ti ve f eedb a c k on 55 secretion (Painson et a1 ., 19 91); in
contrast , fe male rats show a continuous secretory pattern o f
55 a nd the leve ls are higher . These data suggest that the GH
secretory pattern 1s regulated by GHRH and 55 . As for sexual
d ifferences o f the release of both GHRH and SS , some evidence,
which wi ll be p r es en ted i n the fo llowing section, show t h a t
they might be determined by the sexual differentiat i on of the
brain .
1.1.5 Sexual Differentiation of the Brain
1 ,1.5 .1 Def emi n i za t ion and Masculinization
Sexu a l differentiation o f t he brain results from exp osure
to androgen during a s hor t period o f neur al de velopment whe n
ne r v ous tissue is still sufficiently plastic to respond
permane ntly and i rreversibl y to gon adal ho r mon e s . In rats, it
actually consists of two p rocesses, the permanent
defeminization a nd t he reversib le ma s c u l i n i za t i on (MacLus ky
and Naftolin , 1981) .
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The short critical per iod when androgen irreversibly
defeminizes the brain is marked by a suppression of female
characteristics and an enhancement of the potential of the
central nervous system (eNS) to r es po nd to androgen in
adulthood. This process i s " de f eminization" and only depends
on the hormonal environment of the perinatal period . At
puberty, the h igher levels of androgen masculinize the
defeminized brain . This process, termed "ma s c u lin i za tion",
activates masculine characteristics but is not permanent .
Adult castration of male rats can inhibit the male type of
drug metabo lism, but t he drug metabolism can resume to nor mal
after injection of testosterone propionate (TP) to the
castrated males (Shimada et al ., 1987; Virgo, 1991) .
The critical period for a ndr oge n to permanently organi2:e
the brain in rats is from just prior to birth to 10 days
postpartum, ie, t he perinatal period (MacLusky and Naftolin,
1981; McEwen, 1983) . Howe ve r , for the P450 system, the limit
is 5 to 6 days postpartum. If exposure of the brain to
and rogen does not occur , the brain will innately develop
fe male characteristics and the neural control of endocrine
f un c t i ons a nd sexual steroid-related cvecctuoee P450 system
would be affected. The secreecey pattern of gonadotropins is
sexually different, with a cyclic pattern in female rats bu t
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an acyclic or tonic patter n in males. This sexual dimo rphism
r esults f r om the sexual dif fe re ntiation of the bra in . If t he
brains of female rats a r e de feminized with neonatal
t es t os t e rone treatment , the fema le ra t s wi ll show an
anov ul a tory synd r ome due t o t he occurrence of an acycl i c
gona dotropin secre tion . Adu lt male r a t s cast r a t ed between
birth an d 3 day s of l i f e and transp l ant ed wi t h ovarian and
vagi na l tissue ca n d i splay vag i n a l cycles , ovu lation (Ha r ris,
1964 ) and cyc lic gonadotr op in secretion i n a du ltho od (Gorski ,
1966) . Simi l arly, ne on a t al c a s t r a t i on ca uses a compl ete l y
s upp r e s sion o f mal e-specific cytochr ome s P4S0 in adu lt met e
rats bu t indu ces t he express i on of female-specific cy toch r ome s
P4S0 (Jansson et aI. , 1985a).
1 . 1. 5 .2 Morpholoqical Changes of Bra i n an d Neonatal Se:K
Hormon e s
I t is we ll known t ha t there are s exual d i f ferences i n
bra in s t ru cture t hat a r e sex s teroid- d e pen dent. These
d ifference s i nclud e such aspects as s ize of nucle i in neu rona l
groups , number o f neurons (Go r s k i et aI. , 197 8; Breedlove and
Ar no l d , 1980; Gur ne y and Konishi, 1980 ; J ordan et aI. , 198 2) ,
volume of ne u ron s (Gorsk i et al ., 1980) , e xtent of dendr i ti c
extension and br a n ching (Meye r et al. , 1973; Ayoub et a 1.,
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1982), number of dendritic spines ( Greenough et a l . , 1977;
Ayoub et a1., 198 2 ) , a nd morphology (Gill dn er, 1982 ) and
l o c a l i z a ti on o f s y n a pses ( Matsumoto and Arai, 1981) .
In 1966 , Pfaf f firs t discovered the existence of sexual
differe nc e s i n the size of nerve cell nuc lei i n rat brai ns .
Late r , Raisman an d Fi e l d ( 1973) , Dyer ( 198 4 ) , Greenough et al .
( 1977) , Nishi zu ka an d Arai (1981), an d Matsumoto a nd Ara i
(1981 ) found sexua l d imorphisms i n the pattern o f neurona l
con nections in r a t b r ains . All t hese differences p r o ved to be
d epe nd e n t on e xposure of t he eNS to a nd rogen during the
p erinata l pe r iod . For examp le , a n i nject ion o f t e s t o s teron e
into fem a le rats o f day 5 caused a mar ked i nc r ease i n the
numb e r of s haft synap ses ( SHS ) in t he medial amygda loid
nucleus (AMN) . Th e i nc i dence of SHS i n a ndrogenized females
wa s a l most the s ame as that in no r ma l males. I n co ntrast,
neona tal o r ch idectomy r e sulted in a s ign ifici.lOt de crease i n
the number of SHS t o a l e ve l comparab l e to tha t o f no r maI
females ( Nish izuka a nd Ara i , 1981) . I n an o the r e xperiment,
treatment with t estoste r one on da y 5 t o female rats inc r eased
the mean numbers of s haft and s p ine syna pses i n the
hypo t halami c a r cuate nucleus (A RCN)i mcr ecve r , the s y na ptic
o r g an i z ation o f the ARCN in t he a nd roge n ized adul t fema les was
q ui t e homo l ogous t o that observe d i n the no r mal ad ult males
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(Ma t sumoto a nd Ara i , 1981 ) . The se a nd othe r studi e s i ndi cate
that the presence of sex ste roids during the per i nata l pe r i od
Ny peraane n tl y d if fe r e ntia t e the develop ing process o f the
brain and i r r e ve r s i b l y organi z e the brain stru ctur e.
The medial preop ti c a r ea (HPOA) o f t h e hypotha lamus i s
clea r l y impo r tant i n t he cont r ol of go nadotrop in re lease and
sexual be ha v iour ( Pres loc k an d McCa nn , 1987). Also , t h i s a r ea
is g e nerally accep t ed as a ma j or s i t e o f neonata l hormone
actio n during neural development . Within the MPOA is a n area
uf d arkl y s t a i n i n g neurons named the s e xua l l y dimo rp hi c
nuc Ieua (SON- POA) (Gor ski et a 1. , 1980) . The function of t his
nucle u s i s s ti ll not clear and mos t author s su ppo s e tha t it i s
i nvo l ved i n mascul i ne reproductive b ehaviour (Arendash a nd
Gorski , 1982 ; Arend ash and Gor ski, 1983: Gors ki , 1991 ) .
The de ve l opment o f t he SDN- POA start s du ri ng l a te fetal
life a nd ext.ends t hroughout the first t en day s of pos t na t a l
life (Jacobson an d Gorski , 198 1 ; J aco bson e t aI., 19 80) . This
pe riod corresponds t o t hat o f bra in sexual dif fe rentiat ion .
The d e ve l opmen t of SON-POA ne u rons i s dependent upon androqen.
Castration of th e 1- day-old male ra t significan tly r e du ce s
SON- POA volume i n adultho od (Go rsk i et aI., 1978 ; Jacob s on e t
a 1., 1981) , but i mmed i a t e re im p l an t a tion of a testis o r
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injec t i on o f tes tos terone afte r neonatal ca s t r a t i on re e t .cce s
SDN- POA va lump. to norma l (Ja cobson et a l. , 1981 ) . Further,
exogenous tes t os terone g i ven po stnata lly to the ge netic fema l e
sign ificant ly i nc reases t he vo l ume of SDN- POA i n adulthood
( Gor sk i et a l. , 197 8 ; J acobson e t a l. , 198 1) . The r efore , the
SON- POA, a t l ea s t i n terms o f i ts vo l ume, i s clearly
inf luenced by the perinatal horm one environme n t.
The s tructures o f thl.'! ventromedia l nuc l e us (VMN ) and the
arcuate acc reue (ARN) a re also sexually d if f ere nt i n s ynaptic
pattern and nu clear volumes o f neuron s (McEwen et a l., 198 2 ;
Toran- Allerand CD, 1980) . The ce ll bod ies of these nucle i
co ntai n GHRH; i nde e d , t he ARC nucleus is the major s ite of
GRRR in the brain. Fu r t he r mo r e, thes e morp ho l ogi c dif fe r e nce s
in the rat are determined by the neonatal s teroid en v i r onmen t.
Recently, Chowen a nd colleagues (1993) reported that
neonatal and adult testoste r one had e ffects on th e
o r ga n i za tion and activation of GHRR and 5S neurons i n the
hypothalamus . Neonatal t es t os t e r one incre ase d the numbe r o f
GHRR neurons 1n ad u l thood and ad ult t es t osterone s timulated
GHRH mRNA l e v e l s; fur ther , in fema l e rat s , adult testoste ro ne
stimulated GHRR mRNA l e vels , and the magn itudp. of t he i nc rease
was h i gh e r in the a nimals exposed to neonata l t estosterone
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than thos e not expo s ed to ne onatal sex s t eroids . In c ont r as t ,
the numbe r o f 55 neurons was no t effec ted by t e stosterone , bu t
both ne onatal testosterone and ad ult testosterone
significantly increased 55 mRNA level s (Cho we n et al . , 1993 ) .
1 .1.5 .3 Sex Ste r o i ds During t he Neonatal Period
1 .1 . 5 .3 .1 Androgen an d Es t r og e n
I t is known that the serum conce n t r a t i on of t e sto s t e r one
i s significan tly highe r i n male rats than in female ones
d u ring the pe r i nata l pe riod (Pang et; al . , 19 79) . And rogen can
permanent ly defeminize t he eN5 during t he critical per iod of
neural development . I t has been suggested t ha t androgen i s
converted , v i a a r oma t iza t i on , to estradiol, wh i c h i s commonl y
accepted as the precise mol ecula r species of go nadal hormone
that promo tes t he d efeminization of the br a i n ( Doh ler, 1 986 ;
Toran- Allerand, 1986 ; Gorski , 1991) . Administr a tion with
entaeserceene ca n b lock testosterone-induced (Doughty and
McDon ald , 1974) or est rogen- i nduced de feminization ( Doughty e t
a l . , 19 75 ). Furthermore, aromatizing enzyme i nh i b i tor s can
also inhi b it the defeminizing effects of both e ndogenous an d
exogenous testosterone (Booth, 1977 ) . As f o r t he b r a i n -
control led hepatic cy tochrome P450 system, ne onatal
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test osterone o r est rogen de f eminized s ex-depend ent drug
met abol i SIII, and ecoeet.e s e i nhi bi tor p reven t ed the
defe mi n h a tion of he pa tic d rug metabolism i nduc ed by sex
steroids ( Re ye s and Virgo , 1988) . These da t a s uggest t ha t
andr oge n is co nverted t o es t rad iol to defe min ize the bra i n .
Fur t he r , t he fetal an d neo na t al r a t brain contains a r oma ti z in g
enzymes whi ch ca n con ve r t aromat i za b l e a nd ro ge n t o e s t r ad i ol -
17D ( George a nd of e de , 198 2 ; MacLusk y e t a l ., 1985; Lep ha r-t. e t
a l ., 1992 ) , and estroge n r e cep tor l evel s in t he ma la and
fema le rat brain i nc r eas e marked l y du r ing t he per ina t al per i od
(McEwen e t aL , 19 82 ) . The s e evtde nce s s upport t he
poss i bi li t y o f and r og-e n- a r oma t h a tion a nd the i nvo l vement o f
estrad i o l i n the defe mini zing p r oces s . Therefore , i t is
as sumed tha t a nd ro ge n e nt ers the cytoso l o f neu r on and i s
convert ed to est r ad iol by aromat a s e ; es t r adio l the n interacts
wi t h speci fi c r e ce p t o r s and u l t i ma t e ly the ne u rona l ge norne to
a l ter mRNA ac tivi ty wh ich i n t urn s t i mula t es or i nhib its t he
prOduc t i on of s ome product , t he r eby modi f ying ne urona l
f unc tion (DOh l e r , 198 6 ; Toran-A lle rand, 1986 ; Gorski , 199 1 ) .
As fo r t he. e ff e c t s o f s e x ster o id s on nerv e ce lls , i t ha s
been demons tra t ed tha t est rogen or a ndrogen can inc r ease t he
r ate an d exte nt o f neuritic outgrowth i n ne u r o ns co n t a in i ng
es t r ogen re ceptors ( To ran- Alle r a nd , 198 0 ) . The gr owt h and
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deve lopmen t of axons and de nd r ite s in tur n enha n ce synapse
fo rmation a nd neur o na l survival, a nd i nc reases ne uron number .
Sinc e dif ferent ci rcu l ating l e vels o f sex s t ero i ds ex i t
between s e xes during t he per i nata l per iod, number o f synapses ,
the spa t ia l dis t r ibut i on o f s yna ps es, neuron numbe r, neuronal
vo l ume an d neural c i rcuits wi ll s exuall y differentiate . Th is
hypothesis is cur r e n t ly i nvo lve d i n explain i ng t he s exual
morphogene tic mechanisms of t he ster oidal effects during the
neura l deve lopment ( McEwen e t al. , 198 2; To r an -A llerand, 19 8 6 ;
Gorski , 1991).
1.1.5 . 3 .2 a-FBtoprotein (Arp )
Neona t a l f ema les ha ve estrogen-rich plasma, and yet the
brains of female ra ts do no t become defeminized . Th i s may be
due t o the presence of p La a ma a-fetoprotein .
AFP i s a maj or fetal p l asma protein wh i c h is present in
most developing vertebrates . I n rats, this protein occurs in
h i g h concentration during t he first 3 weeks of postnatal life
and decreases l i ne a r l y from its ve ry h i gh concentration t o
trace levels at weaning (Raynaud et a l. , 1971) . Although AFP
c a n bind a var iety of hormones and other b io l og ically active
ligands i n other species, rat and mouse AFP alone binds
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@strcg@ns with a high affinity and pro t@cts th@ de ve Icp Lnq
b rain from exces s ive exposure t o estroqens . Sinc e AFP does
not b i nd and rogens , testosterone i s free t o en te r the roden t
brai n . Thu s , felllale brains do not be come defeminized .
1. 1.5 .4 Hepatic Sex-Dependent Cyt ochrome P450
Bas ed on t h e a bo ve , it can be cc nc iueee t ha t es t r ad i ol
b inds estrogen recept ors in the c ytoso l t o modu la te t he
e xpress ion o f DNA and to organize the de ve l opmen t a l co urse of
t he brains . Si .r\ce the sec r e t ory patt ern of g r owt h hormone in
adult rats r esults from t h e s ex ua l diffe renti a t i on o f th e
b r ai n , and the secretory pattern regu la tes the expre s s i on o f
sex-dependent cy toc h rome P45 0, we can i nf e r t hat sexua l
diff e rences i n the a ctivitie s o f t he cytochrome P450 system
are the result of sexual d iffer e nti a tion of the b r a in . Reyes
and Virgo ( 1988) showed that va:r:ious sex-s tero ids whi c h ca n
de f eminize gonado t ropin sec r et i on also defemin ized d rug
metabolis m, and that a r oraa t a s e inhibi t or wh ich ca n block t he
defemini zat i on of gon a do t r opin s ecretion prevent ed the
de feminization o f hepa ti c cytochrome P4 50 . Therefore, it
suggests that neon a t a l androgen defeminize s hepat ic cy t ochrome
P4.50 possibly vi a t he sexual diffe r entiation of the b r ain .
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1 .1 .6 Catecho1ami ne r gic Sy s tem in t h e Def emin izat10n of the
Brain
1.1 .6 .1 Neona t al c atecho l ami ne s and behav i ou r
In addition to sex steroids, monoamine neurotransmitters
are believed to be involved in the sexual differentiation of
at least some aspects of CNS functions (D6hler, 1991) . Thus,
changing the amounts of these monoaminergic transmitters in
CNS during the critical period of sexua l ' d if f erent i a t i on of
the brain would alter the steroid-dependent expression of
sexually or nonsexually-related behaviours in ad ult rats. It
was repcz-xed that r es e r p i n e , which depletes norepinephrine
from nerve terminals by inhib i t ing uptake i nt o storage
vesic les , co uld prevent the defeminizing effects of neonata l
testosterone in inducing anovulatory syndromes in the females
(Gorski , 1973) . Raum et a1. ( 1990) reported that prenatal
exposure of male rat fetuses to coca ine , which could increase
synaptic concentrations of norepinephrine, inhibit~d sexually
re lated behaviuurs in adu l t males . Reduction of serotonin by
p-ch1orophenylalanine (PCPA) enhanced masculine sexual
behaviour in ma l e rats and potentiated the defemin izing effect
of exogenous t e s t oster one in females ; in contrast, increasing
serotonin by S-hydroxyptophan (SHTP) inhibited masculine
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behaviour i nduced by ex ogenous testos terone i n female ra ts
(Wilson e t al ., 1986) . Neon atal admi n i s trat i on ' o f clonidine
resul ted in a sign if i cant r eduction in the ca pa city to express
female l ordos i s be hav iour in fema l e ad ulthood ( Jarzab e t; al. ,
1987 ) . Neona t a l dopam ine or no r ad r e na line was found t o r educe
the ope.... fiel d act iv i ty i n f emale adul t r a ts (Gonz a lez an d
Leret, 19 92b ) . All the ab ove ev idence suggests t ha t s exua l
differentiation o f sexual b e ha v i our i s related to the ne one t c I
catecholami nergi c system in the brain .
1.1.6.2 Neonatal catecholaminee and r eproduct i ve e ndo c r i n e
function
The sec retory pattern of t he gon adotrop in s i s, as
mentioned previous ly , sexua l ly different, and t hi s sexual
dimorphism of gonadot ropin secretion resu l t s from t he sexual
differentiation of t he brain. If the female bra in i s
de f e mi n i zed with neonatal testosterone t r ea t me n t , the female
rat will be come anovulato ry due to the presence of acyclic
gonadotropin secretion (Booth, 19 79 ; Dt:lrner , 198 1; Goy and
McEwen , 198 0 ). Besides sex steroids, neurotransmitters during
the neonata l period also have effects on the sexua l
different iation of gonadot ropin secretion. A series o f
experiments (Jarzab and Dahler, 1984 ; J ar zab et a l., 1 986,
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1987, 1989a,b,c) demons trated t ha t postnatal treatment of
fema le r at s with the a-adrenergic antagonists prazosin or
yohimb ine, o r wi th the nicot ine receptor antagonist
mecamylamine, significantly i ncreased the release of LH by
gonadal steroids in adulthood; and that postnata l treatment of
female rats with the a -adrenergic agonist isoprenaline, the
B2-adrenergic ago nist salbutamol or B-adrenergic antagonist
alprenolol reduced t he release r e s p o n s e of LH to gonadal
steroids i n adulthood . Undoubtedly, these data indicate
neu rotrans mitters engage in the sexual d i ff e r e n t i a t i on of
gonadotropin secretion .
1 .1.6 . 3 Neonatal catecho1amines and SDN- POA
SDN-POA is t ho ught to be r elated to sexua l behaviour
( Ar endash a nd Gorski, 19 8 2 ; Arendash and Gorski, 198 3 ; Gorski,
19 91 ) a nd sexually differentiated (Gorski et al ., 1980 ) , t he
effect of neonata l c a techo lamines on the anatomy of SDN-POA
h a ve also been investigated . I t was reported ( Handa et al.,
1986) that prenatal p -chlorophe nlami ne, a n i n h i bi t o r o f
sero tonin biosynthesis, i ncre a sed the volume of the SDN-POA in
female neona tes compared to that of control males . Studies
(Jarzab et al ., 1989b , 1990a,b ,c) show that s albutamol , a 132-
receptor agonist, g i ven n eonatal ly , increased SDN-POA volume
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in both f e mal e and male r a t s bu t the effect wa s particu l a r ly
man ifes t i n males; f urthermore , the Ql- rec ep tor agonist
clonidine augment the st imulatory effect o r t e s t oate rcne o n
SDN-POA d ifferentiation i n f e ma l e r ats . These da ta suggest
that a l t e r a tio n of cat e c ho l ami ne l e ve l s i n the neo na ta l brains
would mo d i f y t he sexual diffe rentia tion of the CNS.
1 .1 .6 .4 Catecholamines and andr ogen during t he neonatal
pe riod
The re is e v idence show ing that catechalamines modify the
defeminizing effect of ne o na t a l tes t oste r one . Postna ta l
serotonin delayed the p e r ma ne n t anovu la t ory-sterlli t y ( PAS)-
inducing effect of postnata l testosterone (Shirama et al .,
1975), and PCPA was found to prevent androgen-induced PAS in
f e ma l e rats ( Re z ni ko v e t aI., 19 79). Tyramine , which re leases
no r a d r e na l i ne from nerve terminals, as well as the Ql/a2
receptor blockers p henoxybenzamine and phento lamine can
i nhibi t t he defeminizing action of testosterone on ovulatory
cycl lcity in fema le rats (Raum and Swerdloff, 1981 ). Although
nu clear a c cumu lat ion o f est radiol der ived from the
a r o ma t i za t i on of testosterone is inhlbited by hypothalami c 13 -
recept or stimulat i on in the neona tal female rat ( Ra um e t a L, ,
1984 ) , the work of Can i ck et a l. ( 19 8 7 ) showed neona tal
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administration of the B-agoni.st , isoproterenol, had no effect
on a romatase activity in male or femal :a pups (Can i ck et a l.,
198 7 ) .
In spi te o f that the mechanisms of ne urotransmitte r
e ffects on defeminization is still not known ; the fact of the
i nvolvement of these catecholamines in the de reeunraat rcn of
the brain cannot be denied. Therefore, due to the fact that
sexua l differences of hepatic cytochrome P450 result
indirectly from the br a i n sexual differentiation and that sex
differentiated characteristh.:s can be influenced by adrenergic
agonists/antagonists , we intend to study whethe r the neonatal
adrene rgic s ystem is involved in the androgen-induced
defeminization of hepat ic cytochrome P450 in male rats.
1.2 GH and Development of Male-Specific Cytochromes P450
1.2 .1 Developmental Ezpressions of Male-specific Cyt o c h r ome s
P450
Se x -dependen t cvcocnrceee P450 of rat liver disp lay
developmental c hanges (Waxman et; aI., 1985 ; Imaoka et aI.,
1991). Fo r example, during t he ne o natal period, the amount
of cytochrome r4 50 2Cl 1 is undetectable in both sexe., , but in
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male r ats the amoun t o f t his iso f o rm begins to r i s e at 4 wee ks
of age and reaches its highest l eve l at puberty . The females
show an a l mos t undetec table levels of t he i soenzyme from t he
neonata l period to puberty ( Wa xma n e t a l. , 198 5 ; Imaaka et
al. , 19 91) . Anothe r male- spec ific isoform of cy tochrome P450,
3Al /2, also unde r goes developmental changes, but it mai nly
shows a developmental decline in the f e ma l e s (Waxman et a 1 . ,
198 5 ; Imaoka et a L. , 1991 ) . I n the females, the amoun t o f
this i s oe n z yme is high during t h e neonata l period but
decreases with age . The males , however, keep a high level of
P450 3A1/2 from the neo n a ta l period to puhe rty (Wa x ma n et al . ,
1985; I maoka et a L, , 1991 ) . The ac tivities of zu- and l6a -
testosterone hyd r o x y l a s e s are low i n newborn r ats , bu t rise at
around 4 weeks of age and then reach an adult high level at
puberty; since 2a- a nd 16a - testosterone hydroxylations are
selective f or cytochrome len which i s barely detec t able in
female rats from t h e neonatal period to ma t u r i t y , t he f e mal e s
display l ow activities of zu - and 16a-testosterone
hydroxylases all t he time . en-reeeoeterone hydroxylation,
which is c a t a l yze d by c y t o ch r o me P4 50 3Al/2 , shows a high
activity i n ne wbo rn female but de creases its act ivity wi th
age. I n ma l e s the ac tiv i t y of 6B-hydroxylase rises at two
weeks o f age, reaches the highest at 4 wee ks o f aqe , then i t
decreases bu t arises again a t 6 weeks of a g e (Waxman et a l .,
1985 ; Imaoka et a l ., 19 9 1) .
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1.2 . 2 GH an d Male- Spe cif i c Cytochromea P450
Et hy l morphine demethylase ( EMDM) , a sex - specific he pa t i c
monooxygenase which exists in both s e xes but s hows a much
higher activi ty in ad ult males, is neonatally defeminized by
a ndrogen ( Reyes and Vi rgo , 1988 ; Vi rgo , 199 1) . The ac tivity
of th i s enzyme i n male rats ex h i bi ts developmental ch anges
(Gram et al ., 1969) . The activi t y is unde tectab l e in newbo r n
r a t s , beg i ns to rise a t 4 wee ks of age a nd r e a c h adult l e ve l s
a t puberty . Howev er , the fema les d i spla y a l ow ac tivi t y o f
t h e e nzy me al l t he t i me .
The activities o f £MOM ( Kr ame r et a I. , 1975; Vi r go , 1983;
Vo c ke nt ,mz and Vi rg o , 1985) a nd male-specific c y t ochrolil8s P4 5 0
s uch as 2C11 (Janec zko et aI. , 1990 ; Legra ve r en d e t a I. , 1992)
and 3Al / 2 (Waxman et a l ., 1990) in adul t r ats a re r egulated by
GR. However , there are no r ep orts regard ing the f a c t ors
re s po ns ible fo r the de velopmental expre s s i on o f male s pec i f ic
isofonns during t he prepube r t al period. Plas ma GH immediately
a fte r b i r th appears a t very hi gh leve l s , an d then declines
s ha r p l y to a n almost unde t e c t ab l e l e vel ; it the n be gins ta
r i s e a t 4 weeks of age, and reaches a du l t leve l s at pu bert y
( Khorram e t a I. , 19 83 ; Rieutor t , 197 4 ; Strasser a ni.! Mi alhe ,
197 5 ) .
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Althou':jh the male patte r n of GH secretion is o rgan ized
d uring the neonatal p e riod {J a n s s on and frohman, 19B? } , i t
b ecomes manifest only af te r pu b e rty ( Gabr i e l et a l ., 19 92 ) .
During the prepuberta l period , t here is no apparen t ly s exual
dif f e r enc e i n t he s ecreto r y pa ttern o f GH, the p repuber tal
expres s i on s of ma l e - s p e c i fi c P450 see ms no t re l a t e d to the
s ecretory pattern o f the hormon e . Therefore, we a lso i ntend
to i nv est igate whether GH p l ays a ro le in t he pre pu ber t a l





2 .1 GENERAL MATERIALS AND METHODS
2 . 1 . 1 ChUl icals and Bi o che.ai c als
2 . 1 .1.1 Chemica ls f or anima l i nj@ction
DL-isoprot@reno l'HCI, DL-propranolol ' HCI, c l on idlne -HCI.
phenyl e ph r Ln e s HCI , phentolamine ' HCI • prazos i n ' HCI ,
t e s t o s t e r one prop ionate , and p r opyl e ne glycol were purchased
from Si gma Chemical Compa ny ; WY271 27 is the p r oduc t of W}·gth
Ltd • • Philadelphia, PA, USA; s od i um glutamate (MSG) i s from
G.E . Barbour Inc ., Su s s ex , N .B. ; an d s odium chloride
purchased f rom Fishe r Sc i en t i fi c Company, Nepea n , Onto
2 . 1.1. 2 Chemicals for the en zyme aS 8a y
Glucose- 6-phosphate dehydrogenas e ( G- 6-P - DH), B-
nicotinami de adenin e d i nucleotide pho sp ha t €! ( NADP), g luco s e-6-
phosphate ( G- 6- P ) . oxid ized cy t oc hrome c and reduced B-
nicotinamide adent ee di nu cleo t i de phospha te were pu rchas ed
f rom Si gma Chemical Comp any ; semicarbaz id e hydrochloride a nd
4-oi tropheno l were the p r oduc t s of AIde ~ch Che mical Company.
Inc . , Milwaukee, WI S, USA; magne sium chlor ide , po t a s s i um
c yanide, sucrose and sodium hy drOXi de were purchased from
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Mallinckrodt Canada Inc , Pointe-Claire , Quebec; zinc sulfate,
hydrochlor i c acid a nd sodium dithionite were from Fi s h e r
Scientifi c, Fa ir Lawn, NJ , USA; ethylm orph ine chlorohydrate
and perch l or ic acid were the products of SDH Chemicals,
Canada; l 6a - hydro x y t e s tos t e r o ne ( 4-androste n -1 6a l , 1613-
hydroxytestosterone (4 -andros ten -l613 ), l1a-hyd roxy-
testosterone ( 4-andros t e n-11a) , 7a -hydroxytestosterone (4-
a nd r os t en - 7a ) , 2a- hydroxytestos terone ( 4-a nd r os t e n -2a ), 1 113-
hydroxytestosterone( 4-androsten-l1B ), 6f3-hydroxy - testoster.:>ne
(4-androsten-6B) and hyd r o x ytestoste rone ( 4- a n d r os t e n- l 7J3- 0 L-
3 - 0 NE) were purchased f r om Steraloids, Inc . , Wil t on , N . H . ;
aceti c ac id g lac ia l wa s f r om Baxter Co r po r a t i o n , To ronto, Ont;
and L-ascorbic acid wa s pu rchased from Un ite d States
Bi o ch emi c a l Corpo r at ion , Clev e land , Ohio, USA; glycerol,
a ce t one , me t han ol and d ichloromethane were the p r odu c t s of
Fishe r Scientific Company ; BIC - HAD Protein Assa y Dye Re a g e n t
Concentrate a nd bovine serum al bumin a r e f r om BIO -RAD
Laborator ies , Richmond, CA, USA.
2 . 1.1. 3 Chemicals for buffen
Buffers we r e prepared acco r d i ng to the metho ds described
by Gomod (1955) .
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Trizma base (T r is [hydro xyme t hy l )ami no-met hane) i s the
p roduct o f Sigma Ch emi cal Company ; po 'taas Ium phos p ha t e
monobas ic , potassium phc. sp hate dibasic and potassium chloride
we r e purchased from Malli nc krodt Canada Inc .
2 .1 .2 Animals
Pregnant rats (Wi s t a r) , hav i ng su cc ess fu lly raised a t
::'east one previous litter, we r e purc ha sed from Charles River
Can ad a (St . Constant , Que . ) and were ke pt i n solid-b o t tom
p lastic cages on chemical - free hardwood bedding . All r a t s
were kep t at 2l0C und e r 12h of light per day and had fre e
access to tap water and Agt.;ay PRO LAB c how (man u f a c t ured b y
Agway Inc . , New Yor k, USA) . Newborn a nd ad u lt cats were u s e d
i n all expe r i lllen t s .
2 . 1. 3 I n t raventricul a r Inj ection
On Day 0 an d 3 o f b irth, ne whor n lIla l e ra t s we r e
a ne s t he ti z ed hypot hermically . The pu p was wrapped in a
sl ightly damp piece of gauze bandage a nd placed i n ice for 1 5
mi nutes to i ndu ce hypot he rmic anesthe sia (Pfeiffer, 1936 ) .
Th e pup was then r emov e d f ro m ice, put i n a ho l d e r , and the
head p laced i n a horizon t a l position with t he s kull side up .
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A midsa gi ttal i nci sion was made through the sk i n f r om a line
joining the eyes t o a line j oining the ea rs, and t he bregma
was exp osed . ;.. 271-gauge ne e dle wa s inse r ted ver t i cally i n to
the th ird ven tr icle (coordinates: 0 . 5 mm anteri or to the
:)r e g ma; 1.5 mm l a t e ra l t o t he midsag i ttal f issure ) t o a dep th
2 . 5 mm ventral t o t he s kull surface . The va lid i t y of these
coord i na tes was co nfi r med by i n j e cti ng dye (Methylene Blue-
Certified , Sigma Chemical Company) an d morpholog i cal
exam ination of t he brain after fixation in bu ffered 10 %
formalin . Ten p.l of ve tucae or dr ug solution was i n j e c t e d
i nto the ven t ri c l e ove r a pe riod of 3 minutes and the need le
was ma i nt a i ned i n p osition f o r a further 5 minutes t o prevent
backflow from the puncture wo und . The i nc i s i on was closed by
seal ing the s k in to t he sk ul l wi t h c ya noa c rylate glue .
Afte r the injection, t he pu p was l ef t und i sturbed and
war med until i ts body returned to room temperat u re ( i e. p i nk
an d active again). They were t hen warmed at 25 0C for at least
two hou r s before being returned to the dam.
2.1.4 Castration
2 .1.4 .1 Castration of the neonate
The procedure us e d was a modification of Pf ei f f e r ' s
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method (Pfeiffer , 193 6). Within 12 hour s o f b i r th , the pup
wa s a n esthetize d hypothermi c a lly by p l a c i ng it i n ice f o r 15
min . The pup ·....as then placed , ver.tra l s lde up , on a surg ica l
t able . Th e a rea of i ncisio n was wiped wi th a pi e c e of
Kimwipe1 so aked in 9S% ethan ol. An i nci s ion ( 2 mml was made
through the skin a n t e ri o r to the urogenital papilla a t a 4SJ_
angle to the left (of the pup) by use of very fi ne iris
scissors . The s kin was then f reed from s ub cu t aneous t i ssues
wi t h a fine probe . A second inchion was made h o r iz on t a ll y
t h r o ug h the muscula ture a t the body wall o f tile i nit ial cu t.
The r igllt testi s was then extruded by slightly pressing tile
abdomen and excised with a pa ir of s cissors. Tile l eft tes ti s
was exposed by care full y probing through t he viscera a nd a l s o
ex c ised . The wound on the body wa ll was c l os ed by a lig ning
t he cut edges o f the musculature with s ma ll f orceps and then
seal ing it with cy a noa c r y l a t e glue . The open ing o n the skin
was then c losed by o-..erlapping the cut edges of the s k i n and
seal ing i t with cya no a c r y late glue . After t he su rgery. t he
pup was left und isturbed, warmed and returned to t he dam .
2 . 1 . 4 . 2 Castration of adult r ats
The rat was lightly anesthetized with ether a nd p lac ed,
ve n t r a l side up , on a surgical table. Th.e limbs were fixed t o
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the t a b l e . The ha ir on t h e scrotum was r emo ved with a pair of
eu r qt ce, , s c i s sors and t he s kin of t h e sc ro t um was wiped wi th
75% ethanol. An i ncis i on was made through the midline of the
scrotum fol lowed by a second incision through the tunica of
one tes tis . The tes tis was then e xposed, the test icular
artery and vein were liga t e d, and t he testis was excised . The
remaining testi s was r emov ed similarly . The scrotal incision
wa s c l o s ed with 3 to 4 su tures.
2 .1.5 Subcutaneous Injections During t he Neonatal Period
On Day 0 t o 10, chemicals we re injected under t he dorso-
latera l skin of the pup i mmed i ate l y posteri o r t o the front
limb.
2. 1.6 Preparation of Microsome
The met hod us e d t o p repare h epat ic microsome wa s based on
tha t r e ported by Virgo ( 1991 ) .
Fo o d was r emo ved f rom the rat twelve ho urs before it was
k i lled in order to dec rease glycogen i n the live r . The r a t
wa s decapitated with a gu illot i ne and exsanguinated . The
a bdome n was opened with a pair of su rgica l scissors a nd the
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int a c t liver was e x cised as quickly a s possi b l e . The liver
was then put int o a beaker of i c e-c o l d SO JlIM Tr i s HCl buffer
pH 7 .4 , conta i n i ng 15 0 mM KCL Afte r t he liv e r was r i ns e d. i t
was t ak en ou t . wi pe d dry with a pie c e or Klmwipe' to re move
blood a n d we i g hed . The t rv e r wa s then put i nt o a be a ker
c o n t ain i n g 3 v olumes o f ice-co ld SO mM Tris HCl buffer pit 7 . 4
with l50mm Kel . ho mogenized with a Br in kmann Po lytro n a t
setting of 4 i n a 4°C co ld room . The homogenate was t hen
centrifuged a t 9000 '9 f o r 20 minute s at 4°C . The r esu l t an t
s upe r na t a nt wa s t hen ce n t r ifuge d at 10 5 , 000 ' g at 4°C f o r 60
minut es . The supe r natant was po u red o f f and a s i mila r vol u me
of f r e s h SO mM Tris HCI buffer pH 7 . 4 wa s adde d . The
microsomes wer e re suspended with t he homoge ni ze r a t s e t t i ng of
3 . The s u s pens i on was cen t r i f uge d o nce aga i n a t l OS, 000 '9 for
60 mi nutes at 4°C. The supe rn atant was d Ls ca rded an d t he
pel let wa s ho mog eni zed i n a volum.:! o f SO laM Tr is HCI buffer p H
7 .4 e qua l to half t he volume of 9 , 0 0 0 'g s upe r natant orig inally
co ntaining the lIlic r o some s . Glycerine ( 20\ of t he volume of
t h e suspens ion ) was added an d the micro s omes were sto r ed a t
- 80 °C until use .
2 .1 . 7 Mea surement of Micros omal Pr o t e in
Co n cent r a tio n o f mi croso ma l prote i n wa s de te r mi ned
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according to the Bradford's method (19 76) using the Bio-Rad
Protein Assay kit:
Diluted microsomal protein ( 1 : 3000 and I : 6000 ) (0. 8ml)
and Q. 8ml o f standards (bovine serum a lbumin 21.J.g jml, 31.J.g jml,
4pg jml, 6pgjml a nd 8].1gjml j were placed in c lean, dry test
tubes, a nd O.8ml dist illed water was p laced in "b lank" test
tube . Dye Reagent Concentrate O. 2ml was then added to the
t e s t tubes . All test tubes were shaken without caus ing excess
foaming . After 5 minutes, the absorbance of the blank
standards a nd samples were measured at 595 nm , The value of
protein concentration was calcu~ated from the standard curve .
2 . 1.8 Enzyme Assays
2 .1.8 .1 Measurement of e t h y l mo rp h i n e demethylase (EMDM)
activity in hepatic microsome
The activlty of EMDM was measured in vitro from the
amount of formal in produced from the methy l group released
from the substrate (Nash, 1953). The incubat ion medium
contained t he following in a total volume of 3 ml: 0 .1 mM
NADPH, 1 mM NADP, 3 .3 mM glucose 6-phosphate, 2 Units glucose
6-phosphate dehydrogenase, 1.0 mMsemicarbazide, 24 mMMgCI2'
3.
50 mM Tris Hel bu ff e r ( pH 7.4), 6 rng microsomal protein, a nd
6.7 mM e thylmorphine. After 5 min of p r e Lncuba t Lon o f t he
mixt u re , the protein was added to the incubation nu a tu r e a nd
the r e a c t i on wa s a llowed to proceed f o r 20 min at 37 JC unde r
air. The react i on was t he n stopped a fter 20 min by a dding 2 ml
2 0 % ZnSOt and 2 ml saturated Ba (OH )2 to the incubation mix.
Af t e r t he addi tion of 3 mI of distilled water, the r e s u l t a n t
s uspens ion was centrifuged a t 3500 r pm for 15 minutes. F i v e
ml of t he supernatant was removed to another tube containing
2 rol double strength Nash Reagent (150 9 anunonium acetate , 2
ml acetylacetone, 2 ml glacial acetic: acid and diluted to 500
ml with distilled water) , and t h en h e a t ed at 6 0 ~C for 30
mi nu t e s . The absor bance wa s then measured i mmediately at 41 3
Concentration o f formalin in t he original i ncubat ion mi K
was calcu lated by : formalin ( nmo l/ml) '" (ABS - 0 .0069 ) / 0 . 0006 .
This equation was obtained by u sin g k n own concentrat ions of
formalin in the Nas h reaction ( Nash , 1 9 5 3 ) .
The concentration o f MgCl 1 used i n the incubation was 2 4
mM, which wa s de termi ned with prelimi na ry experiments to
select an appropriate MgCl 1 concentrat ion . We used 1 . 2 , 12 ,
2 4 , 48 and 96 roM MgCl1, a nd f oun d that the amo unt o f product
was highest at 24 a nd 4 8 mM Mg C12• S i n c e there was no
apparent difference i n t h e amount of product between 24 and 4 8
mM MgCl 2 used, we dec ided to use 24 roM MgC12 f o r the reaction.
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The incubation time wa s 20 min . I n cu ba t i on o f t he mi x
to-: 5, 10, 20 and )0 mi nutes , r e s p e c t i v e l y show ed t ha t the
specific a c tivity o f ethyl morphine de methy l ase was the sallie at
5 , 10 and 20 minute incubation and l ower at 30 mi nu t e s (see
Ta b l e 2-1) ; there fo re , 20 mi n was chos e n .
2 . 1.8 . 2 Meas urement of p-nitrophenol hydro zylase (p -NPH)
act ivity i n hepa t ic microsome
The activ ity of p-nitr ophenol hydroxylase was measured in
v i tra according t o the method of Koop ( 1 986 ). The incubation
medium contained t he following in a t o t al vo l ume of 1 ml : 0 .1
mM p- ni t ropheno l so l ution , 0. 5 mg mi cro s omal p r ote in, 1 mg
NADPH an d 100 mH ph os ph ate buffer p H 6 .8 . After 5 min t)f
preinc ubat i on, NArJPH was add ed t o start t he reac tion and water
was ad ded t o the refe r en ce. The react i on was a llowed to
proce ed for 6 min a t 37°C un der ai r an d s t opp ed by add i ng 0.5
1111 0 . 6 N perchlor i c ac i d . This mi xture was then ce n t rifuged
fo r 15 min at 35 00 rplll . At l as t, 0 . 1 ml of 10 N NaOM was
added to 1 ml of the centrifuged supernatant , an d the
absorbance of t his s olution was mea sure d at 546 om . The
concentration of t he product , n i t r oc a tec hol , was calculated
using a mil limol e extinction coefficient of 9 .53 m?f1cm· 1. The
amoun t of the product was shown in p reliminary experiments to
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'I'able 2- 1 . Hepatic EMD1'l activity of intact and castrated male
rats Wider different incubation time .
Incubation Time
(minute)















Tab le 2 -2 . Hepatic p -NPH a ctivity o f male r a t s under
different amounts of microsome protein & various i n c ub a tion
time .
( n i trocatechol J
( Microsome 1 ( nmol/mi x . )
(mg / pe r mi x. ) ------------------------------------
4 mi n. • mi n . s mi n.
0.1 0 . 44 1. 04 2 .20
0.25 1. 35 2.03 3 .13
0 .5 2.28 2 .68 4 . 3 7
L a 3 .33 4 . 73 5 .82
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be pvopor t Lc n a.l to both the t ime of i n c uba t i on en d t he
concentret i on o f :nicrosomal p r o t e i n (see Tab le 2- 2 ) .
2 .1 .8 .3 Quant i t a t i on of c ytochrome P4 50
The concentration was determined by the method of Omura
& Sato (1964).
A few mi l lig r a ms of sodium dith ionite we r e ad ded to the
2 . 5 ml mt croeomes suspende d in 50 mM Tris Hel buffer ( p H 7.4)
(2 mg/ml) in a c u v e t; to r ed uce t he cytochrome P450 . Th e
absorbance of the s uspens ion was then measured from 40 0-50 0 mn
y ielding a baseline . The suspens ion was then b ubbled with
c a r bo n monox ide for 30 seconds and i t s absorbance was measured
from 400- 500 n m based on the ob ta ined ba sel ine . Two differen t
values of absorba nce we r e selected to calculate , using a
coeffi e nt E as 9 1 mM-1c m-l , t he concent ra tion of cytochrome
P4 50 . The total P4S0 nmo l /mg o f the microsome is given b y the
f ormul a :
(ABSm-ABSm ) 1<1000/91/ mg MP.
In t he above formula , . ABSm' was the a bsorbance at 450
nm and ' ABSa o' the abso rbance at 490 nrn.
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2 . 1 .8. 4 Measurement o f NADPH eyt.ochrome c r educ tase
Th e activity ~f t h is e n zyme was determi ne d by the
p roc e du re of Phil li p s a nd Langdon (1962) usi ng 19 .6 CfQ·'mM·1 as
t he extincti on co e ff ic i ent for reduced cytoc h rom.;!: c a nd 1 001llM
ph osphate bu ffe r for the react i o ns .
Cne ml of 50 l1M c y t o c h r ome c r e a ge n t ( 1 .86 mg ox i d ize d
cytochrome c in 1 . a ml of 10 0 mM ph ospha t e bu f fe r , pH 7.6) and
1 ml o f I roM KeN' (1.96mg i n I O. Oml 100 roM phos phate buffe r , pH
7 .6), 90 pg microsome ( lOOlJ,g mi c r os omal protein in 1 .0 ml of
100 RIM phospha te buffer , pH 7 .6 ) were a d ded t o bo t h reference
an d sample cc ve ee . The n , 0 . 1 ml of 100 roM phosphate buffer pH
7.6 buffe r wa s added to t he r e ference c uve t , a nd t he
absorba nc e o f the mixture measured , wi th
spectrophotollleter under the funct ion of time dr i ve mode at
550 om , t o ob tain a ba seline . The reference cuve t was then
replaced with the s ample cuvet . NADPH 40.9 J1M d i s s o lve d i n
10 0 1I1 o f 100 111M pho sphate buffe r , pH 7 .6, was added to t he
sample cuvet ; the a bsorba nc e of t he mixtu re wa s measured
immediate l y . Two va lues o f t he absorbance were s e l e c t e d t o
calculate t he act iVi ty based on t he f o r mul a:
(A BS1-ABS1) "'3"'1000 / 19 . 6 / time / mgMP.
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I n t he above fo rmula, 'A BS: ' a nd - ABS:' were t wo values
o f the absorbance, '19 .6 ' was the coeff icent, ' 3 ' wa s the
volume of t he mix t u r e , ' 100 0 ' was us ed whe n millimo l e was
conv e r t ed to nanomole, and the - t i me ' was t he period between
t he two ebso rbances selec ted .
2.1.8. 5 Kine tics o f e t hylmorphine deme thylase
The method to measure the kinetics of EMDM is i de n t ical
t o t ha t fo r t he measurement of EHOM a c tivi ty excep t t hat t he
concen t ra t i o n of e thylmo r ph i ne varied, co ntaining of 0 .42,
0 .84 , 1.68 , 3 .35 or 6 . 7 roM e t hy lmo rphi ne. The va lues of Km
an d Vma x a r e o btaine d bas ed o n the follow i ng calculation :
ABS =b[E M] +a
Km=b/a
Vrnax=l / a
I n t he a bov e formul a s , ' ABS ' was t he va l ue of a bsorbance ,
• [EM] ' was t he concentra t i on of ethy lmorphine . Formu l a
ABS=b [ EM]+a wa s obtaine d by line a r r e gre s sion ana l ys i s ;
t herefore , " b ' wa s t h e s l op e o f the c urve, an d ' a ' was t he
intercept of t he curve with the o r dinate .
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2.1.8 .5 Measurement o f 2a - , 16a-, and 58 - test osterone
hydroxylases
Cytochrome P450 2e U is the ma jor mal e - s pec i fi c P4 50 and
is responsibl e for t he h yd r o xyla t ion of te s tosterone i n the 2a
a nd 16a posit ions ; cytochrome P450 3A i s an o t he r mal e s pecif i c
P4 5 0 and is r e s pon sible for t es t ost e rone hydro xy l a t i on in the
66 po s it i on. Thus, we measured the activ ities o f the s e
hyd r oxy l a t ion reaction s to observe the mal e -specific i soforms
of he pa ti c P4 50 2eU and 3A.
The i nc ub at i on me dium conta ined t he f ollo wing in a t iot.e L
vo lume o f I ml (Wood et al ., 19 83) : 1 mg micr osome protein , 1
mM NADPH, 3 mM Mg ICI*6HIO, 50 mM sucro s e, 2. 5 mM testosterone
(4-andr o sten-176-ol -3-one) (dissolved a nd added in 20 u L of
methano l J a-ad 50 filM p ho s p ha te buffer pH 7 .4 buffer . After 5
min of pre incubat i on , t he testosterone was added a nd the
reac tion wa s allowed to proceed fo r 5 min a t 37 °C under the
air . The re action was stopped by adding 6 ml dichloromethane .
After .ni x i ng f o r 30 seconds , the liquid was centrifuged at
10 0 0 r pm f o r 5 mi n . Then 5 ml o f t he d ichloromethane was
t r a n s fe rred to a 50 ml con ica l centrifuge tube and evaporated.
Af ter e va poration, the residue was d issolved in 100 pI o f
solven t A (43 0 ml methanol + 11 ml acetone + distilled water
to 10 00 ml) a nd a nal y z e d by HPLC.
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The a mou nts of 2a - , 16a-, and 6f3-tes to!iterone
hydroxylases we re d e t e rmi ned wi t h a Beckman System Gold h igh
p r e s su r e liquid ch roma tog raphy (HPLC) system by the method o f
Wood e t a 1. (19 8 3 1 . The p umps were 118 So l vent De li v ery
Modu les, the sample wa s pla c e d o n t he column wi t h a mold 507
Autosamp ler , coo rdinated wi th an Ana l og I nterface Module Mold
406 ; p r odu c t s we r e i d e n t i fi ed with a Programmable De t e c t o r
Module 166 . Th e column u sed was a Su pe lcos il LC-18 f rom
Su pe l co , Inc ., Be lle t o n t e , PA, USA. Th e par t i c le size of
pack i ng wa s 5 um , Th e s olven t s y s t ems consis t ed of solvent A
( 4 30 ml met ha nol + 11 ml a ceton e + distilled water to l OOOml )
a nd s o l vent 8 ( 750 ml met h a no l + 19 ml ac etone'" d i s ti ll e d
water to 1000 ml ) . The flow rate was 1 . 5 ml / min . The co l u mn
was de velop ed by a concave solvent gradient ( Programme 4)
beginning with 100 % s o lvent A an d progressi ng to 100% solvent
B o v e r 25 mi n . The c o lumn was washed f o r 8 mi n with 10 0 %
so l vent A b e f ore eac h s amp le i njection. Testoste rone , 1 6a-
hydroxyt6stosterone, l 6B-hy d r oxytes t osteron e , lla- hy dr oxy-
testosteron e , 7a - hyd rox y t e stosterone, 2a - hy droxytestoSl t e rone ,
llB-hydroxy-testosterone a nd 6 B-hydroxyte s t o s eer one , cn esc i v ed
in 1 00 % so l ve nt A, we r e an alyze d a t various co ncentrations t o
obtai n r etentio n times a nd t o generate s t a ndard curv es. The
r etention t i me o f t e s t os t e r on e was 1 7. 4 :tO. 03 mi n (7.0) .
12 . 4±O .OS min (l6a) a n d 9 .05:!: 0 .07 min (613) . Th e
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con c e ntrations of testosterone produ c t we r e calculated
a c cord i n g to t he follow i ng t'ormulas , wh i c h were obtained by
u s i n g known concentrations of testosterone in the HPLC sys tem:
f o r height of p e a k : (2a) yO'15 . 30 38 4X+O. 1485 12
(16a) Y; 13 . 81535X+O. 138008
(6B) '[=17 . 578 9 8X+O. 134990
for area of pe ak : (2 a) Y" O. 0 53 739X+0. 1538 37
( 16a) Y;O . 037555X+O.157820
(68) Y; O. 05 1997X+O. 1 5578 6
In the a bo ve f o rmu l as , ' y ' was the conce n trat ion of
pro du c t , and . X ' wa s the height o f p e a k or area of peak
depend i ng what fo r mu la was used. Using e i the r height o f p e a k
o r a r ea of peak wou ld g i ve sam e r e sults .
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2. 2 ANIMAL PROCEDURES
2 . 2 . 1 ae r e of Adrenergic a ecepeer e i n the Ne on atal
Defeminizat ion of Hep atic On: I Metabolism i n Male Rat s
2 .2 .1 .1 Drug metabol i sm in male rats c astrated neona tally a nd
given a- or a-adrenergic agonists or antagonists and
testosterone propionate ne onatally
To i nve stigate t he r o l e s of adrenergi c receptors and
t he ir relation with a ndrogen in t he de f e mi ni za tion of he pa t i c
c y t o c hr ome P450 s ystem, we castrated mal e pups wi thi n 12 hr
after birth a nd adm in i s t e r ed (icv) isoprotere no l (50 P9
d issolved i n salin e), phento lamine (25 119 di s s o l ve d i n
s aline), phenylephr ine (5 0 P9 dissolved in sa line) or WY27127
(5 0 P9 di s so l v ed i n s aline ) on Day 0 & 2 . Some of t hes e rats
we r e g iven ( s c ) 1 . 45 pmol tes tos te ro ne propionate d i s s o lved i n
propylene gly col on Day 0 , 2 & 4 , while t he rest rece ive d the
c arri e r . Th e rats we r e weaned on Day 28 and were kil led on
Da y 65 f o r t he enzymati c assays .
2.2 .1. 2 Drug metabolism in male r ats g iven a- or B-adr energlc
agoni sts or an tagonists neona tal l y
To t est whe ther a - o r B- adren ergic re cep t ors are invo l ved
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in the de f emin i zation o f he patic c yt o c h ro me P4 50 en zymes, we
tre ate d ( i cv ) male rat pu p s o n Day 0 & 3 af ter b i r t h with
i s o p r o t ere no l ( 50 ]lg dissolved i n sa l ine ), c lonidine (50 pg
dissolved in saline) , phe n y l e ph r i ne ( 50 ]lg dissolved in
saline ) , p ro pa no lo l (5 0 lJ9 dissolved i n saline), prazosin (50
lJ9 dis s olved in saline ) or WY 27127 ( 50 ]lg d issolved in
sal ine) . The control g r oup was g i ven saline . Since pu ps from
the same dam are more a like than those f rom different dam's
due to genet ics , dam I s behaviour, etc , , pups from different
dams were mixed up toge t he r . Different li tter sizes load to
di fferen t nutritional sta tus for the pup s , t he litter s ize was
reduced t o 10 pups to minimize t he bias of mean values . The
rats were wea ned on day 28 af ter b i r t h , castrated on Day 55 to
eliminate t he masculinizing e.dect of androgen i n adulthood ,
and killed on d ay 70 fo r th~ enzymatic assays .
2.2.1.3 Drug metabolism in male rat s g ivr.n propranolol
together with other adrenergic agents neonatally
To study the exact ro le o f a and B receptors i n the
deteminization of hepat ic cytoch rome P450 enzymes, we treate d
( i cv) male rat pups on Day 0 & 3 after birth wi t h WY27127 (50
]l9 i n 2S ]ll saline ) , clonidine (50 ]lg in 25 pI saline) ,
phe nylep r i ne (50 pg in 25 u I saline), phentolamine (25 pg in
25 u t saline 1 or p razosin ( 50 pg i n 25 ]ll saline ),
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respectively, together with propranolol (50 J.1g in 25 ]JI
saline ) . The rats were weaned on day 28 after bi rth ,
castrated on Day 55 to eliminate the masculinizing effect of
androgen in adu lthood, and killed on day 70 for the e nzymatic
assays.
2 .2 .2 Monosodium Glutamate (MSG) and the Prepubertal and
Pubertal Dev elopment of Hepatic Cytochrome P4S 0
System in Ma l e Rats
2 .2 .2 .1 Drug metabolism In 35-day-old rats treated wi th MSG
during the neonatal period
To study whether g rowth hormone (GH) plays any role in
t he pre-puber ta l de ve l op me n t of male hepatic cytochrome P450 ,
we gave male newborn pups MSG subcutaneously to destroy g r o wt h
hormone re leasing hormone (GURR) cells in the arcuate nucleus.
The rats were then assa ye d o n Day 35 .
On Day 1 , 3 , 5, 7, & 9 after birth , ma l e pups we r e gi ve n
subcutaneously 0 , 2, or 4 mg MSG dissolved in salinejg body
weight. The li t t e r size was 10 pu ps. The rats we r e wea ned on
Day 28 and kil led on Day 35 f o r the enzymatic assays.
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2 . 2 .2 .2 Drug metabo lism in 65 - day-old r a t s give n MSG
dur ing t he neonat al per iod
To investigate the role of GH in the expression of
he p a t i c cytochrome P4 50 system, we ga v e male newborn pups MSG
t o obse rve the hepatic c y t o ch r o me P450 system.
On Day 1 , 3 , S, 7 & 9 after birth, male pups we re
inj ected ( s c ) with 0 , 2 or 4 mg MSG diss olved in saline / g body
weight. The l i t t e r size wa s 10 pups . The rats were weane d on
Day 28 a nd killed on Day 65 f o r the enzymatic assays .
2 . 3 STATISTICA L ANALYSES
Data we re ana lyz e d f or ov e ral l signif icance by an one way
ana lysis o f v a r i anc e . When a diffe rence was f ou nd a t p<O . OS ,
post-hoc tes ts ( Bon f e r r o n i t t e s t s ) be tween selected pairs of
g r ou ps we r e c o n duc t ed.
Values of protein conce-rt.ra-t t c n were calcu lated b y
l ine a r reg r ess ion ana lysis using a CASIO scientific calc u lator
p r o g r a mme d for linea r regression analys is .
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3.0 RESULTS
3.1 THE HEPATI C CYTOCHROME P450 SYSTEM: EFFECT OF ADRENERGIC
DRUG ADMINISTERED NEONATALLY
3.1 .1 Effect of Phento lamine an d Isoproterenol on
Defemi nizat ion in Neon atal Castrates Defeminized with
Exogenous An d rogen
To t est whe the r, i n the absence of testosterone,
a -adrenergic r ece ptors might stimu late d efe minization
whether B-adrenergic r eceptors might inhibit the pr oc e s s ,
us ed phentolami ne ( a l/aj - adr e nergi C: antagonist) a nd
isoprotereno l (BI/ Bl- a d r en erg i c a g on i s t ) in neo natally
castrated ma l es a nd o bserved whethe r d e femin i z a ti on was
affected .
3.1. 1. 1 Hepatic ethylmorphine demethyl a s e (EMDM) activity
The activi ty of hepatic: ethy l morphine d e methylase i n
intact adul t ma les was 9 .11:1:1 .12 nmol /m in/ mg , 6 .6-fold t ha t o f
the females (p< O. Ol) ( Table 3-1) . Neonatal castration, as
expected, prevented the defeminization of h epati c EMDM
activity as t h e activity in t he ne on a t a ll y castra ted ma les wa s
1. 70 ±O.1 4 ( 1.90 & 1.50) nmol/min/ mg, wh i c h did not differ
(p>O .05 ) from t hat i n t h e fema les .
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Table 3-1. Effect of ad renergic ag ents on hepatic EMDH and
p - NPH activ ities in neo n ata l c astrated d e f emi n ize d wi th
exogen ous an drog e n. The activi ties of he pa t ic e thylmorph ine
dem e t hylase ( EMDM) & p-nit r o phe nol hyd roxyl a s e (p - NPH) i n male
r a t s c a st r a t e d wi t hin 12h afte r hi r t h, t reated with 25 pg
phen t olami ne (PH ) o r 50 pg isop r ote r e n o l (ISO) (L c v • on Day 0
& 2 ) t og ether wi th or wi t ho ut 1 .45 pmo I t e stos terone
propionate ( TP) t sc . on Day 0, 2 , & 4), & a s sayed on Day 70 .
Treat men t EMDM Ac t ivity p -NPH Act ivity
( n mol /mi n/mg) ( nmo l /m i n/ mg)
I n t act
"
9.11 ±1.1Z1 1. 37± 0 .17
I n t a c t , 1 .39±0 .10b 1. 32 ±0 . 12
gd +vehic l e 1.70±0 .14b 1.70±0.25
( 1. 90 , 1. 50 ) ( 2 . 0 6 , 1 .34 )
g d +PH 0 .9 7±0 .36b l . 62 ±0 . 14
(1.48, 0 . 45) (1. 82, 1.42 )
g d +PH'I"TP 2.33±0 . 06 c 1. 06 ±0 . 02
( 2 . 25, 2 . 41 ) ( 1. 02, 1. 09 )
gd +I SO 1 .8l± 0 . 6lb,c 1.3S ±O. 12
Va lue i s ex p ressed as MEAN±SE; one replicate in cuba ti on was
performed fo r each sample .
a Si gnif i cantly different from b ( p <O. Ol ) & c ( p <O. 05) ;
b Significantly d iffe r e n t from C (p <O . 05 1.
gd' : c a s tra t e d male
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The activity of hepatic EMDM i n neonatally castrated
( femi n i ze d ) male r at s given phento lamine or isoproterenol on
Da y 0 & J did no t d i ffer (p>O.05) from tha t in females ( Ta b l e
3-1) . Th is s ho ws tha t p h e ntolamine (PH ) or isoprotereno l
(ISO) do not cause defemini:z:ation in the absence o f
t estosterone. When t e stos t e r one wa s given concurrent ly with
p he n t o l amine , the EMDM ac t ivity signif ican t ly increased, by
67% (p<O .05) , o ve r t hat of t h e i ntact fema les . Thus , a lthough
t he defemini :z:ation was no t as great as on e would expect
{n orm ally 75% of adul t values , see Virgo , 1991} , the drug did
no t prevent i t . The s ampl e size, ho wever, is smal l.
3 . 1 . 1 .2 Hep a t i c p- n itropheno l hydroxy l a s e (p - NPH) a ctivity
Th e ac tivity o f p - n f t.r-o phe nc l, hyd roxylase , as e xp ected,
did not display s e xual d iffe r e n ces (p>O.05) (Ta ble 3-1).
Neonatal castration did no t effect p-N PH activity . Gi ve n
ph e n t o l a mi ne , p h entolamine plus testosterone o r i s oprote r e nol ,
t he castrated rats d i d not s how a n y chan ge in p -NPH e c u t v r t y
(p >O. 05 ) (Tab le 3- 1 ). The data indicat e t hat cast r ation,
t e s toste rone, phen t o l ami ne, o r isoprotere nol ha s no inf l uen ce
on t he no n- sexually diff e r ent i ated p -nitrophe no l hy droxylase .
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3 . 1 . 1 .3 Hepat.ic cYt o c hrom e c reductase activi ty an d
cytoch rome P4S0 amoW1t
The act.iv it.y o f c y toch rom e c reductase: and t.he t.ot. a l P4 50
did ltOt. show a significant. di f f ere nc e ( p> O.OS ) be t wee n i n t ac t.
ma l es a nd f emal e s , a nd neon a t.a l cast.rat.ion ha d no effe c t s on
these pa r amete r s (Tab l e ) -2). The ad min i st. rat. ion of PH, ISO ,
or PH p l us t.estosterone did not a l t er s ignif i cantly Ip >0.0 5)
the tota l amount of P4 S0 (Ta b l e 3- 2 ) o r the reductase activi t y
( Figure 2) in the adult rats castrated ne o nata lly . These
l a t t e r data sugges t t ha t the increase of EMDM activ ity i n
testosterone a nd ph e n tol a mi ne - t r e a ted rats does not re sult
fren: an inc r eas e of eith er the amoun t o f P4S0 or the
r e d ucta s e .
Due to t he l e ng th of t ime re qu ired t o conduct thes e t yp e s
o f exper i me n t s and the high IllOrtality we expe rienced in t he
ne onata l cast rates (up t o 70 %), we deci de d t o p ro ceed to ou r
main i nves t iga t ion o n the roles of adren erg i c receptors i n t he
defeminization pro ce ss.
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Tab l e 3-2 . Effect o f adrenergic a gen t s on hepatic cytochrODlB
c r educ tase activ i ty and cy t ochrome P450 amoun t i n ne onatal
castrated defeminized wi th exog en ou s androgen. The t o t a l
a mou nt of hepat i c c y t o c h r o me F45 0 " the ac t ivi t y o f he pa t i c
c yt ochrome c r e d ucta s e in male rats castrated wi t h in 12 h
after birth , trea t e d with 25 l-l9' ph en t olamine ( PH) or 50 l-lg
isop r ot e renol ( I SO) ( i c v) on Day 0 Eo 2 tog ethe r with o r
without 1 . 45 1111I01 testosterone propionate (TP) ( s c) on Day 0 ,
2 , Eo 4, " assayed on Day 70 .
Treatment Cy t . P450 Cyt . c Reductase
(nmo l j mgMP) (nmol jminjmg)
I n t a ct d 0 .97±0. 10 96: 7
I ntact 2 0. 64:0 . 02 95:5
gd+vehicle 0 . 72 .±0 . 04 10 9± 2
(0 .77, 0.66) (1 05 , 112)
gd +PH 0 .72tO .05 113:!: 4
( 0 .79, 0 .65) ( 11 9 , 108 )
glt+PH+ TP O. ShO . Ol 7ltl
( 0.52, 0.50) ( 69 , 73 )
gd+I50 0.67 t O.02 10 1tlO
Va l ue s are ex pressed as MEANt5E; Va l ue s are not significa n t l y
diffe re nt (p >O.OS) within co lumns . One replicate i ncubation
was performed f o r each s amp l e.
g<l: cas t rated male
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3 .1.2 Ef f e c t o f Neonatal Adren e rgi c Agents on De f emi nized
Cytoc h r ome P450 System
3. 1. 2 .1 Hepatic e t h y l morphi ne deme thylase activity
It is well known t hat ne on atal t e s t os t e r one de feminiz e s
EMDM acti vity whi ch by d ef i nit i on , r e f ers t o a permanen t
increase in e nz yme activ i t y cou p led with t he c a pa c i t y fo r a
fur ther reversibl e i nc r e a s e in a c tiv i t y upon e x pos u r e t o
androgen in a d u l t ho o d ( ie . mas c u lin iza t i o n) . Defemini zation
is best measured by the permanent incre ase i n act ivity and
t his can be unmaske d by simply ca s t r ating t he adul t . We chose
to castrate o n Da y 5 5 as this is five day s a f te r pu b e r t y wh ich
begins on Day 35 and extends f o r 14 Days (Oj eda o t a l. , 19 80 1.
The assay was co nd uc t e d on Day 70 when a ny androg en e f fects
had di s sipa t e d .
The activitie s o f he pa t i c ethy lmo rp hine de methylas e i n
intact ad ult males, mal e s castrated on Da y 55 (po s t pube r t a l)
and intac t adult f e male r a t s were 6 .641CJ. 18, 2 . 791CJ . 26 and
O. 9 CJ 10. 06 Mlo i / mi n /rng (Ta b l e 3-3). These results show t hat t he
hepatic activity of EMDM in adult male rats i s 7 - f o l d higher
t ha n t hat of the fe males (p< O.OI ) . Ca stration of postpubertal
r ats de c r e a s e d the EMDM act ivity, a lthoug h th& activity wa s
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Tabl e 3-3 . Effect o f n e o n a tal adrenergi c a g e n t s on he p a t i c
EMDM and p-NP H activit ies in defeminized male rats. The
act ivities of hepatic ethylmorphine demethylase (EMDM) & p -
nitrophenol hydroxylase (p-NPH) i n male rats treated
neonatally with 50 pq isoproterenol (ISO) , 50 P9 propranolol
(PRO ), 50 Ug phenylephrine {PRY} , 50 pg c l o n i d i n e (eLO) , 50119
WY27127 (WY) or 50 pg prazes !n (PHA) o n Day 0 & 3, cas trated
on Day 5 5 , and assayed on Da y 70.
Treatment EMDM activity p-NPH activity
(nmol/min/my) (nmol /min/mgl
In t a c t d 6 . 64 ±0 .IS! 1. 25 ±0 . 08
gd 2. 79±0 .26b 0 .94±0 . 10
gd+veh icle 2 .46±0.28b 1. 25±0 . 12
Intact , 0 .9 0±0 .06c 0.98 ±0 .24
gd+ISO 3. 00±0.99b 0 .94 tO .03
gd+PRO 5 .56±0 .60a 1. 20tO .OS
gd+PHY 3 .14±0. 79b 0 .86±0 .18
gd+PRA 6 . 06 ±1 .361 0 . 82 ±0 . 0 6
g d+ CLO 2 . 74±0 . 73b 1. 1 8±0 .10
gd+W'f 2 .65±O.16b 1.05tO .08
Va l ue s are p resented as MEAN±SE; One replicate i ncubatio n wa s
performed fo r each sample .
a Significantly diff e r ent f rom b (p <O.05) & ~ (p<O.Oll within
b SCi09~i~fcantlY d i fferent from a (p <O.05) & c (p<O .05l with in
c o l umn;
e Significantly different f rom a (p< O.O l) Eo b (p<0 . 05) wi thin
column.
gd : castrated male
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not c ompletely depressed ( p<O .O S) an d was highe r tha n t ha t i n
t he f ema l es (p<O. OS ) (Tab l e 3-3) . Thus , t hese data show t hat
the neonata l de fem inization in the males i ncrease s th e hepa ti c
EMDM a ctivity o v e r the levels i n the f e ma l es, and t hat
masculinization at puber t y elevates t he de f emini z e d EMDM
activ i t :r· to a much higher l e ve l.
Since t here was no significan t difference in the EMDM
act ivities between cast r ated male ra t s and cas trated male r a t s
given t he ve h i cle on ly (T a b l e 3-3 ) , the i n j ec t ion procedure
d id not affect t h e res u l t s and t he change of EMDM a c t i vi ty i n
the an imals i njected wi th adrenergic d r ugs only ref lects the
e f f e c t s of the drugs.
The EMDM act ivity a t Day 7 0 of male rats castrated a t Day
55 and given , neonatally, isoprotereno l (ISO) , propranolol
(PRO) , phenylephr ine ( PHY) , c l oni d i n e (eLO) , WY27127 ( WY ) o r
prazos in (PRA), 3 .00±0 .99, S .S 6±O. 60 , 3 .14±0.79,
Z. 7 4 ±O. 73 , Z.5S±0 .16 or 6 .06±1 .36 nrno l /min/mg, r e s pective l y
(Table 3-3 ). The activities of EMDM in both t he propranolol-
and the prazosin-treated groups were i nc r e a s ed approximatel y
2.5 fold ( p <O. OS ) compared to that o f t he defemin ized males
given on l y vehicle neonatally, and di d not differ ( p>O. OS )
from the l e vel s i n int act males . This res ul t s ho ws t h at t h e
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neonatal inhibition of one o r both B-adrenergic rec eptors or
preeoem i n hi bi tion of the Cll-adrenergic receptor leads to a
"super- de fem in ization" of hepatic EMDM in the males . This
"s up e r - de f e mi ni z a tion " does not di f fer i n magni tude from that
i n normal rats whe r e the tota l a ctivity re p r esents
defeminiza tion a nd ma s c uliniza tion (Tab le 3-3) . Ther efore ,
these resul ts sugges t tha t in the norma l a n imal t he ar -
adrenergic agon ist complex i nhi b i t s def emini z ation.
Alternative ly , blockad e of the a t - adr ene rgi c r ecepto r may
permit more of t he no repinephr ine i n th e s ynap se to bind to a
stimu latory re c e p t o r . Similarly , t hese data s u ggest t ha t at
least one of t he a - a dren e rgic r ecepto r is i nhibi t ory t o
defemini za t i on (or t hat B blockade increases n orepine phr i ne
f or binding to a stimu latory r e ceptor ) .
The animals , treated wi t h ISO , PH'{, eLO o r WY s howed no
significantly dif feren t (p>O. OS) activity of EMDM, compar e d
with the vehicle control under th e con ditions used (Tab le 3 -
3) . As n e i t he r c lonidine nor WY27 127 i n fluen c e d the
de feminization p rocess one mig ht spe c u l ate t ha t the 0.2-
ad r e nergi c receptor is no t i nvolved in the pr oce ss of
defe miniza tion . However, o n ly one dose was u s ed an d other
dose s may have demonstra t ed e ffects . Si milarly , the app arent
l ac k of effects from ei ther PHY or I SO ma y re f l e ct inad equa t e
6 2
dose s rather than a l ack of ago n i s t ef fec t ( eg . max i mal
defemi nization f r om endogenous agoni s t s ).
3 . 1 . 2 . 2 Hepatic p-n itrophenol hydroxylase activity
The hepati c p-NPH act! vit ies i n i ntac t mal es, mal es
castrated a t Day 55 and intact fema le r at s we r e 1 .2 5 :!:O.08 ,
0 .94±O . 1O and 0 . 9 8±0. 24 nmol /min/mg (Ta b l e 3-3 ). The s e da ta
show that there is no sexual difference ( p>O. OS) in he pa t ic p-
NPH activity, a nd that castration nei ther stimulates nor
i nh i bits p -NPH activity (P >O. OS) ( Ta bl e 3-3) . The animals ,
given ISO, PRO , PRY, CLO, WY or PR}\. , d i splaye d ne i ther an
increase nor decrease in he p a t i c p -NPH ac t iv i ty . The ab ove
data , therefore, i mp l y that t he neona ta l s t i mu l atio n or
inhibi t.I cn of a - or J3- ad r ene r g i c receptors do not affect the
hepat ic p-NPH activity . This i s what was ex pected from thi s
enzyme, which i s not sexually d if f e r e nt i a t ed , and serve d as a
con tro l in our e xperiments .
3 . 1 . 2 . 3 Hepatic cytochrome c reductase ac t i v i ty
I n t h i s exper iment, there wer e no s ig nif icant differences
i n the hepati c cytochrome c reductase ac tiviti es between
int a ct ma l es , males castrated at Day 55 and inta c t femal e
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r at.s; no r we r e t.here a ny signi fi ca nt. differe nc e s i n the
reduc tase ac t.i vities bet.ween animals r nc e i vi ng di fferen t drugs
and i nt.a c t males, males cas t rat ed at. Da y 55 or intac;'t females .
Intac t ma l e rats had a value of 11 1 : 8 nmol / min /mg, and intac t
fema l es 87:HO nmol/mi n/ mg ( Table 3- 4 ) . The value of the
reduc t ase act.iv i ty i n defeminized male rat.s was 98:9
nmol / min/mg, which d i d not differ (p>O . OS) f r om those of
e i t her int.act. males or females . Def eminized animals given
adrenergic ago nists or ant.agonist.s exhibit.ed values of ranging
from l0 2 ± l3 to 87: 7 nmol /mi n/mg. Howeve r , none of t.hese
agent s influen ced t h e reductase a ctivity (p >O. OS) ( Ta b l e 3-4) .
Thus, t.he a l t e r a tion of hepati c EMDM act i vity s ee n with PRO
and wi t.h PRA does not arise f rom a change in t he reductase
activi ty .
3 . 1 .2 .4 Hepatic cyto c hro me P45 0 amount
The leve l of c y t.oc hr ome P450 i n int.act. male rats (0 . 7 9
nmoml /mg prot.ein ) was 31% higher (p <O. OS) than that i n intact
femal es (0 .60 nmol /mg protein ) ( Tabl e 3- 4 ). Post.pubertal
ca s t ra ti o n s i g n if ican tly reduced (p<O.05 ) t.he l e ve l in males
t.o t.hat. of females . However , these sma ll differences i n the
t o t al amount. o f cy tocr h r ome P450 s e e m unlikely to correspond to
t.he 6- f o l d dif f e r en c e s in EMDM activity (Ta b l e 3-3 ) between
these a n im a l s . Propranolol, however, i n c r eas e d the amoun t of
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Table 3-4 . Ef f ect o f neon a t a l adrenerg i c ag e nts on hepa t ic
cytochrome c ee e ceee e e acti v ity and cytochr ome P450 amount in
defeai n i zed ma le r a t a . The t o t a l amount of hepati c c y tochrome
P4 5 0 " t h e act i v i ty of hep a t i c cytochr o me c reductase of ma le
rats t r e a ted ( icv) neonatally with. 50 pg i s op r o t e r en o l ( IS O) ,
50 pg propranol o l (PRO ) , 5 0 I1g phenylephr i n e ( PRY>. 50 ~g
c l o nidine ( eLO ) , 50 lo19WY27127 ( WY) o r 50 119 prazosi n (PM ) o n
Day 0 £. 3 , castra ted o n Day 55 , and assayed o n Da y 7 0.
Tr e a tme n t Cyt . P450 Cyt . C Redu ctase
( nmo l / mg MP) ( nmo l / min/ mg )
I ntact d O.79±O.04ol IU ±8
g d O.a2t O . 0 3b 98±9
gd +vehicle O. 6a ±O. 0 4h,e lOl±8
I n t a c t • 0 .60±O .04
b
,e 87 !lO
gd +150 a .62tO .04b,e 10014
gd +PRO a. a 2 t O. OJ ol 100.t6
gd+PHY 0 .6 5±0 . 03b, t 10 21:13
qd +PRA 0. 67 ±0.02ol,b,e 8 9 13
gct+CLO O. 75±O. aa l,e 93±8
gd+WY O.6J±O .OJ h,e 87 17
Value is expressed as MEAN!5E: o ne r e plicate incubation wa s
performe d fo r each sample .
ol Si gn if i cant l y di ffe rent f r om the g roups witho ut ol with i n
column;
Significantly dif f erent from t he g r oups vntbout b within
co l umn :
e Signi fi c ant l y d i ffe rent from the g roups withou t c wi t h i n
c olumn .
gd : cnstrated male
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P450 in "super-defeminized" male rats up to t j .o levels f o u nd
in i n t a c t adu Lt, males j u s t as i t t ncrease d the EXDl'I activity
up to t hat o f i n t a c t mal es (Table 3- 3). In contrast, PRA
wh i c h also caused "super-defeminization" did not signi~icantly
increase the P4S0 level s , ho we v e r the sample size i s small and
p e r h a ps not r e pre s e n t a ti ve . Propranolol (PRO) is a competive
n-edrenerc tc a ntagonist and has equal affini ty for /3: a nd /3t
r e c e pt o r s ; t h u s i t i nhibits both /31 a nd /32 receptors ( Ho f f ma n
and terkow rt.e , 1990 ) . This drug has be en reported to h a ve
effects on sex ual differentiation of the b r a i n , which was
a ttributed to its /3-antagonism (Mc Gi v e r n e t . al . , 1986) .
Since PRO ( n-ecreoercrc antagonist ) i n c r e a s e s the total amou nt;
of P4S0 but PRA (a-ad renergic an tagonist) does not, t he
"supe r -defeminizing" mechanisms of PRO and PRA ma y be
di f ferent . The o ther groups disp layed a 20% decline in the
P4S 0 amount (Table 3-4 ) ; however, they d id no t signif icant ly
diffe r ( p >O. OS) from the castrated cont rol groups, so that no
dru g effects can be attr ibuted.
3 .1.2 . 5 Kinetics of hepatic EMDM i n PRO- i nd u c ed "super-
defemi n ization"
Since proprano l o l caused "super-defeminization" of EMDM,
investigated the ki netics of EMDM i n the propranolol -
t r e a ted r a t s . However , s ince PRA induced high mortality and
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we had to repeat the e xp eriment on thf! effect of PRA; by the
time •....hen we obtained the data, we did have enough t ime t o
fur ther investigate the kinetics of EMDM and the activities of
testosterone hydroxylases under the i n fluence of PRA.
Th e values of the apparent Km in i ntact males, castrated
(defeminized) males and castrated ( d e femi n i z e d ) males t.rce t ed
with neonata l propra nolo l wer e O.55:!:O .06, O.6 4:!:O.04 and
O.73 ±O. 10 mM (Table 3-5). Th e r e wa s n o signi ficant dif ference
(p>O.05) between these val ues among the three grou ps , which
suggests that the "super - defeminiza tion" of the EMDM act rvt t y
does not result from a c ha n ge of Km. These results s uggest
that since t h e Km of an enzyme is a co nstant, p roprano lol did
not significantly c h an g e t h e r e l at i v e p r o po r t i o ns of t h o s e
isoforms that de me t hylate ethylmo rph i n e in t h e microsome.
The v a lues o f Vmax wer e 6 .96:!:l .04 , 7 .15:!:O.40 a nd
3 . 13 ±O. 36 nmol/minjmg (Table 3-5 ) fo r the defeminized rats
g i v e n PRO, intact males , and d e fe mini z e d r ats . The Vmax of
the rats treated neona t a lly with PRO was n a t s ignificant l y
d if f e r en t from that o f i ntact controls (p>O.05) but was 2.22
time s greater t ha n t h e d e femin i z ed controls (p<O. Ol) (Table 3-
5). Thu s , t he PRO induced "super-def eminization" is a sso c i a t e d
wi th an increase in the Vma x of t he isoform{ s) of P450 t hat
d eme t h y l a t e ethylmorphine. Howe v e r, i t is not possibl e t o
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Table 3-5 . Kinetics of hepatic EHDM in propranolol-super-
defeminized rats . The apparent Vrnax ( nmol/mi n / mg ) and Km (mM)
of t he hepatic ethylmorphine demethylase (EMDM) in male rats
treated with 50 ]lg propranolol (PRO) ( icv) on Day 0 & 3 ,
castrated on Day 55 , & ana lyzed o n Day 70 .
Treatment Km Vmax
(mM) (nmol /min /mg)
PRO+castrate 0.73±0.10 6 .96±1.04*
Intact 0.55±0 .06 7 .15±0.40'
Castrate 0 .64:1:0.04 3 . 13 :1: 0. 36
Va lues are expressed as MEA±SE; one replicate i n cu ba t i on was
pt:lr f o r me d for each sample .
'Significantly different from cast rate (p<O.Ol).
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infer whether the increased Vmax resul ts f r om more enzyme( s 1
or f r om a more active enzyme(s).
3 .1.2 .6 Hepa tic 68-, 160- , an d 2a-testosterone hydroxy1ases
i n PRO-induced "super-defemin i zation"
In order to determine whether any of the major male
specific isoforms of cytochrome P450, namely 2eU an d 3A1 /2
might b e affected b y propranolol, we me a s ure d the activ i ties
of 68-, 160- and 2a-testoste ro n e hydroxy lases •
The values of the enzyme activities in defe mi nized male
r a t s wi th propranolol trea tm ent, i nt act males a nd defem i n ized
ma l es (6B) 0 .84 ±0.OB, 0 .80±O.12 a nd O. 19:tO .IO
nmo l / mi o / mg i (I5a) 1.41±O. I3, 1.41±O.lO, O.58±O .lO
omol/ mi n /mgi (20) 1 . 2S± 0 .I4 , 1 . 32 ±O. 09 , O. 56±O. 10 nmol /m in/ mg
( Table 3-6 ) . The activities of 6B-, 16a-. a nd 2a - hy droxy lases
in PRO-treated group we r e i nc r e a sed 342%. 14 3 %. and 123% o ve r
t h e de feminized co n t ro ls ( p<O.O l) . Si nce t he 68 -hydroxy lated
p roduct i s the r e a te- a nd ster eo - s e lect i ve p r odu c t of
c ytochrome P4 5 0 3A1/2 whi l e t he 2a - and l 6a-pr od uc t s , which
a re usually pre sent in 1: 1 r at io (approxima t ely 1:1 i n our
resul ts), are s electively p r odu c e d by t he P450 2CU Ls o f o r m,
PRO- induced "super- defeminizat ion" i s associa ted wi t h
increased act ivities of t h e isoforms, 3Al / 2 a nd ZCIt.
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Table 3- 6. Hepatic 68 - , 16a- , ~ 2a-testosterone hydrozylaees
in pre-pranola l- i ndu ced superdefemi nizat ion . He pa t i c 68 -, 16 a,
& 2a- t estos t e rone hydroxylase act iv i t ies in male r a t s treated
wi t h 50 119 propranolol (PRO ) ( i cv ) on Da y 0 & 3, ca s t r ate d on
Day 55 , & analyzed o n Da y 7 0 .
Treatme nt 6B 16a 2a
(runo1 / min/ mq) (nmo1/ ml n/ mq) ( nm0 1/mi n / mg)
e no-ce eerete 4
In tact
Ca s tra t e
O. BUO.OS
0 .80 tO. l 2
0 .19±0 .04t
1. 4 1tO. 13
1. 4 ltO . 10
O.5B:tO .10t
1. 25:t0 . 1 4
1. 32:t0 . 0 9
0 . 56 :t0 . 10·
Value s are ex pressed as MEANtSE; ODe r e plicate i n cubati on was
p e r f ormed f or each samp le .
· Sig ni f i cantly dif fe re n t from PRO+castrate and Intact wi t hin
each col umn (p <O. Ol) .
7 0
3 . 1. 3 Ef fects of Neo natal Ad r ene r g i c Drugs i n PRO- Treated
Neo nates
I n this experiment, neonata l males we r e in jected with PRO
neonat a l l y to produce "supe r - de fem inizat ion" . However , o t her
adrenergic agonists a nd antagonists were g i ven simul taneously
t o determine their i.nfluence on t he "su pe r - d e f e mi n i zati o n " .
Al though PRA also i ncreased defeminizat ion, the effects of
o t her adrenergic agen ts on PRA- i nduced "super -defemi n ization"
was no t tested due t o the high mortality caused by PRA.
3. 1 . 3 .1 Hepati c e thylmorphine deme thy1as e activ i t y
Administrat ion of CLO o r 'IN to t he proprano lo l -treated
defeminized ma l e s did not cause significant d i fferences
(p >O.OS) in EMDM activity, co mpared to the PRO-treated
castrated males ( Tab l e 3- 7 ) , whi ch had been de monst rated to be
"super-defeminized" i n the pr e v i ous exper iment (Table 3-3) .
Thu s , these da ta suggest that the aCadrene rgic receptor i s
not involved in the de fe minization . PH dec reased t he e nzyme
a ctivi t y by 35 % ( Table 3-7) , but the decline was not
s i gnificant (p>O .05)i the refore, a mixe d u j /u 2 antagonism does
no t a ppea r to significantly alter PRO-induced "s u pe r -
defeminization" . PRY inc reased t he e nzyme ac tiv i ty by 56%
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Table 3-7 . Effect of neonatal adrenergic agents on hepatic
EMDM and p-NPH activities in proprano lol -superdefem i nized
rats . The ac tivities of hepatic ethylmorphine demethylase
(EMOM) & p-nitroph e nol hydroxylase ( p -NPH) in male rats
treated neonatally (icv) with SO ]lg propranolol (PRO) p lus 50
1J.g WY27'.27 (WY) , 50 119 clonidine (CLO), 50 119 phenylephrine
(PHY) , 25 ]l9 phentolamine (PH) o r SO pg prazosin (PRA) on Day
o & 3, castrated on Day 55 , and assay ed on Day 70.
T r e a t me n t EMDM ac tivity p -NPH activity
(n mol / min/mg ) (nmo l /min /mg)
gd+PRO 5 .4 7±1. 16" 1.03.t0 . 09
gd+PRO 4 . 27±1 . 13 c 1.03±0 .08
.wy
g d +PRO 6 .42:1 .741 1. 02±O .06
+CLO ( 4 .68 , 8 . 15) (0.96, 1.07)
g d +PRO 3 .S7±O .24 t 0 . 94±0.07
.PH ( 3 .81, 3 . 33) (1.00 , 0 .87)
gd +PRO 8 . 54,t1.90" 0 .8 hO . OS
+PHY (10.43 , 6 . 64 ) (0.85, 0 . 7 6 )
9d+ PRO 2.90:tO.54b 1. 19 ±0. 16
..PRA
Va lues a re expressed a s MEAN.tSE; one repli c a t e i n cub a tio n
was p erforme d for each sample.
a Not significantly d ifferen t ( p>O .05) fro m g d'+PRO wi thi n
b ~:;~~fcantlY d ifferent ( p<O .OS ) from gd +PRO wi t h in
COlUnUl;
t No t significantly diffe r en t (p> O.05 ) from g el'+PRO within
COlUnUl .
g el': castrated ma le
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though again this effec t was not s ignificant (p >O.05). Thus,
stimulating the a I-adrenergic receptor had no significant
effe ct on t he "super-defeminization" , and this may be du e to
the full occupancy of a I-adrenerg i c r e c e p t o r s by
norepinephrine . Unexpected ly, PRA depressed the "super-
defeminized" enzyme llctiv ity by 47 % ( Tab l e 3-7); the value of
the depressed activi ty was 2. 9 0±O . 54 nmol /m in/mg , whi c h was
significantly d ifferent ( p <O. OS ) from that in proprano l ol-
treated male rats . Therefore , a I- a d r e ne r g i c agonist complexes
inhibit the process of defeminization.
Based on the above data, st imu lation of the aj -adrenergic
receptor i n h i b i t s defeminization and, under physiologica l
conditions, does so maximal ly; at lea s t on e of B-adrenergic
recepto rs inhib its defeminization, and does so maximally und e r
physiologica l co nditions . However, the results s uggest t ha t
t h e r e may be a stimulatory receptor, which might be 131 or /32'
o r another unkn own receptor, for the defeminization . Thus,
blockade of ei ther a l- o r B-adre ne rgic r e c e p t o r s wo u l d pe r mit
more nore p i ne p h r ine to bind with the stimulatory receptor and
induce "super-defeminization" . Sim i lar ly, the a2-adrenerg i c
r e c e p t o r may inhib it defeminization since blockade of both al
and BI/Bl -adrenerg ic receptors, i n whi c h the aI -adrenergic
receptor is still open to norepinephr ine, suppresses "s u pe r -
defemin i zation " .
73
3.1 .3.2 Hepatic cytochrome c reductase a ctivit y and the
amount of cytochrome P4S0
The ac tiv ities of he pa t i c cytochrome c reductase 1n the
anima ls treated neonatal ly wi t h PRO plus W , CLO, PRY, PH o r
PRA were 8 9t 8 , 106:10 , 83:2 , 74 !:l2 a nd 70±4 nmol /min/mq ( Table
3- 8) , and we r e not significantly differen t (p >0 . 0 5) from those
of the proprano lol-treated, ca strated male s (8 l t.17
nmol /min/mg). The a mounts o f hepatic cytochrome P4S0 in t he
an im al s given ad rene rg ic agent s we r e similar l y not altered
( Tab l e 3- 8 ) , compa r e d to the proprano l ol- tre~t ed , castrated
males ( p> O.Os J . The inhibit ion of PRO- induced " s upe r-
defeminization" by PRA is t herefore not med iated by a de crease
in either tota l cytoc hrome P4S 0 or cytochrome P4S0 reductase ,
and suggests t ha t PRO- e f f ect on P4s 0 3Al /2 ~nd 2en ma y no t be
affected by PRA.
3 .1.3 . 3 Hepatic p-nitrophenol hydrozylase activity
The va l ues of hepat ic p -NPH acti v ity of the male rats
t r e a t ed n eo na tally wi t h PRO p lus WY, CLO, PRY, PH or PRA were
1.03:1:0.08 , 1.02t.0 .06 , 0 .94:1:0 .07 , 0 .8110.05 o r 1. 19 :1:0 .16
nmo l/mi n/mg, respective ly ( Ta b le 3-7 ) . Non e wer e significant ly
different ( p>O. OS) from those o f the propranolo l -treated,
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Table 3-8 . Effect of n e on a t a l adrenergic agents on hepat ic
cytochrome c r ed u c t a s e activity and cytochrome P4 5 0 amount in
propranolol -superdefeminlzed r a t s . Total amount of hepatic
c y t o ch r ome P450 a nd the acti v i ty of cytochrome c reductase i n
ma l e rats treated (icv) neonatally wi th 50 ].1g prop ranolo l
(PRO) p lus 50 ].19 WY27127 (WY) , 50 ].19 clonidine (CLO) , 50 ].19
p h enyl e phrin e (PRY) , 25 ].19 phentolamine (P H) or 50 ].19 p raz o s i n
(PRA) on Day 0 & 3, castrated on Da y 55, and assayed o n Day
70 .
Trea t ment Cyt . P450 Cyt. c Reduc tase
( nmol jmgMP ) (nmol/ mi n j mg)
g d .. PRO o. 6 2±O. O2 81±17
9 C1+ PRO 0 .6 4:!:0.01 89t8
.wy
gd .. PRO 0. 65± 0 .04 10 6±10
"CLO (0.61, 0 .68) (96, 116)
gd+ PRO 0. 58±0.02 83±2
.PH ( 0.60, 0.55) (81 , 85)
g d +PRO 0 .69tO .02 74:!:12
+PHY (0.71, 0 .67) (86, 62)
gd +PRO 0.64±0 .02 70t4
+PRA
Valu e is e x presse d as MEAN±SE ; Val ues are not significantl y
diff erent (p> O.OS) within columns. On e replicate i n c ubation
was p e rfo r med f or each samp l e .
g d : castr ated ma le
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castrated males. Therefore, neonatal stimul ation or
i nhib i tion of adrenergic receptors does not influence the non-
sexually differentiated p-NPH act ivity in adulthood.
3 .2 THE HEPATIC CYTOCHROME P450 SYSTEM: EFFECTS OF MONOSODIUM
GLUTAMATE (MSG) ADMINISTERED NEONATALLY
3 .2 . 1 MSG Effect s in Mal es Assayed on Day 35
It has been r e po r t ed (B loch et al., 1984) t hat MSG
damages GHRH cells i n t he neonata l arcuate nucleus and thus
abolishes the release of g rowth hormone ( GH) in the adults .
Th e role of GH i n maintain ing t he sex d iff e renc e s of the
hepat ic cytochrome P450 enzyme system is well un de rstoo d i n
adult rats , but there in no i nformat i on f o r i ts ro le in
prepubertal rats . Thus, we t reated neonatal male r a ts wi t h
var ious amounts of MSG and observed t he hepat i c cytochrODle
P45 0 system in prepube rtal a nd a du lt rats .
Male r a t pups were g iven 0 , 2 or 4 mgjg MSG on Da y 1 , 3 ,
5 , 7 , & 9 of life, r e spe c t ively , a nd a na lyzed o n Day 35 an d
65 . In this e xpe riment, we have obtained dat a wh ich show t hat
ne onata l MSG ha d no inf luence o n t he prepube r t a l hepa t i c EMDM
( Ta b l e 3-9) . S ince ne o na t a l MSG can decrease s erum GH
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Table 3 -9 . Ef f e ct o f neona'ta l MEG o n he pa tic EMDM and p- NPH
IIctivi ths at Day 35 . The activit i e s of hepati c e thylmo rp h i ne
demethylase (EMDM) & p-nitropheno l hyd roxy l a se ( p- NPH) i n male
rats t r eated wi th lllonosodi Ulll g l u t ama t e ( MSG) (0 , 2 o r 4mg /g ,




( nmol /m i n /mg )
3 .4hO.44
3 .43tO. 18
3 . 63 :10. 37
p-ioIPH A.c t ivity
( nmol/min/rng)
1.51± 0 . 23
1.40:10 . 20
1.38tO . 21
Va l ue is expressed as MEANtSE; The va lues are not
significantly different with i n each column (p>O.05). One
r epl i ca t e i nc u ba t i o n was pe r f o r me d f or each sample .
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(Bloch et a l. , 198 4 ) and t he activities of EMCM at Day 3S we r e
n o t decreased by neonatal MSG, p r e pubert al development of EMDM
seems t o be independent upon plasma GR. Th e act i vities of
EMDM at Day 35 were ap:;>roximately 25% higher than that of
defeminized rats (T able 3-3 ) ; thus , defemi ni:r.ation still
o c cu r r e d i n MSG - treated r a t s and t he increase of EMOM a c t ivity
at Day 35 probab l y reflects the increase of other plasma
ho r mo ne s .
The reductase activities and the total amoun ts of
cytochrome P450 in t he 0 »a/c . 2 mg/g a nd 4 mg/g MSG groups of
35- da y- old rats were not significa n t ly different (p>O . OS)
(Ta~ l e 3-10) . Th e data s uggest tha t GH d o e s not i nfluen c e the
p r e puber tal reductase act i v i t y o r the t o tal amoun t of P450.
The prepubertal p -NP H activities in MSG- t r e a ted rats were
n ot significant ly diffe rent c o mpa r i ng wi th the controls
( p>O .05) (Ta b l e 3-9 ) and t he y a ll r e a ched a dult l e ve l s .
Th e r e f ore, t hese data indic ate , as expected, t hat GH i s also
unrel a t e d t o t he p r e puberta l deve lopmen t of p - ni t r o phenol
hy d roxy lase a nd p -NPH activity seems to r e a c h adult l evels
early before puber-ty ,
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Table 3-10 . Effect of neonatal MSG on hepat ic cyt oc hr o me c
r eductase activity and cytochrome P4 50 amount at Day 35 . The
total amount of hepatic cytochrome P4 50 S. the ac tivity of
hepatic cytochrome C reductase in male r ats t reated with
monosodium glutamate (MSG) (0, 2 or 4mgjg, s c ) on Day 1, 3, 5 ,
7 '" 9 of life, assayed on Day 35 .
Dosage




Cyt , c Redu c tase
( nmol jm in j mg)
4 0 t 3
40 :!:l
42 t 2
Value is e xp ressed as MEANtSE; The values are not
significantl y different wi thin each column (p>O . 05) . One
repl i c a t e incubation was performed for each sample.
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3 .2 . 2 MSG Effe c t s i n Mal e s As s ayed on Day 65
3 .2 .2 .1 Hepatic EMDM a ctivi ty and p-NPH a c tivity
I n 6S-day- old r ats, 2 mg/g and 4 mg/g MSG caused a 50 %
and 43 % increase ( p< O.01) in EMDM activity respecti ve ly ( Tab l e
3-11). These data imp ly that EMDM activi t y i s i n v ers e l y
re la ted t o GH afte r puberty . However, neither 2mg/g nor 4mg/g
MSG al tered t h e activity of p-nitrophenol h yd r o xyl a s e (Table
3-11) and these data i mp l y t h a t GH i s no t related t o adu l t
p -NPH activity .
3 . 2 . 2. 2 Cytochrome c reductase acti vity and total amount of
cytochrome P4 S0
At 4 mg/g MSG, the total amount of cytochrome P4 S0 was
s ignificantly i ncreased (p< O.01) by 2 6% but i t was unaffected
by 2mg/g ( Table 3- 12 ). The reductase wa s unaffected by either
dose of MSG ( Ta b le 3 - 1 2).
3. 2.2.3 Kinetics of hepatic EMDM
Sinc e t he increase i n EMDM a ct i vity t hat MSG caused might
have been related t o changes in c y t o c h r ome P4S0, we examined
the kinetics of the EMDM in MSG treated rats .
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Table 3-11. Ef f ec t of neonatal MSG on hepatic EMDM and p- NPH
acti v ities at Day 65 . The activ ities of hepat i c ethylmorphine
deme thylase (EMDM) & p-ni tropheno l hyd roxylase ( p - NPH) i n male
rats treated wi th monosc.'dium glutamate (MSG) ( 0 , 2 or 4mg / g,
s c j o n Da y 1 , 3, 5 , 7 & 9 o f life, & assayed on Day 65 .
Dosage
{mg / g }
EMDM Activity
(nmol /min/mg )
6 .68:!:0 . 51
10 .04:!:l .061t
9 .521 0 .7Su
p-N PH Activi ty
( nmol/min/mg)
0 .86:0.10
O.8 H O. 0 7
0 .69:0 . 13
Va l ue is expressed as MEAN:!:SE ; one replicate i n cuba t i on was
performed for each sample.
tlSignificantly different from controls (p< O. Ol) .
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Table 3-12 . Effect of neonatal MSG on hepatic c y t ochrome c
reductase a ctivity an d c y t ochr o me P45 0 amount a t Da y 35 . The
t ota l amount o f hepati c cytoc hrome P-45 0 & the act ivi ty of
hepatic cytochrome c reductase in male rats treated with
monosodium glutamate ( MS G ) (0 , 2 or 4mg /g, s c I o n Day 1 , 3, 5,
7 & 9 of life, & assayed on Day 65.
Dosage




0 . 53 ±0 .01
0 .67±O .OS"





Value i s e xpressed as MEAN±SE; one replicate i nc u ba t i o n was
performed for each sample .
HSignificantly different (p<O . 01) from other do ses.
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The apparent Km o f EMDM in 65 day old rats treated
neonatally with Omg/g, 2mg/g , o r 4mg/g MSG a re presented in
Table 3-13 a nd are not significantly different ( p >O.05 l from
each other. Thus , these data suggest tha t t he in crease of
EMDM activity does not result from an change in Km and suggest
that there is no change i n the i s o f o r m compos i ti on of t he
e nzymes .
I n ccnt r e s t , the apparent Vl!lax of EMDM in MSG-treated
male rats wa s increased dos e- d epe ndent l y (Table 3- 13 ) wi t h
t ha t of t he group treated with 4 mg/g MSG being s i gnificantly
i ncreased (p <O.05) by 38%. The re fore , t he inc rease of EMDM
activity i n t he ne ona t a l MSG-treated a nimals ca n be related to
a n elevation of t he Vmax , whi c h ililp lies an i nc r e as e i n the
amount of t he isoforms r e s pon sib l e for ethylmorphine
deme t hy lation or an in crease i n their ac t ivi ty.
3 .2 .2 .4 Hepatic 68 -, 16a - , an d Za - t est os t e r one hyd roxylases
To inves tigate the activiti es of s exually differentiated
isofor ms of he pa t ic P450s i n MSG-tre a ted mal e r a t s , we
measured t he activities of 63 - , 160- a nd Za-testosterone
hyd r OlCylases . The 6BM hydrolCy l ated product is regio- a nd
ste r eo -select ively produced by cy tochrome P450 3Al/2 while the
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Table 3-13 . Ki netics of EHDM in 65-Day-old male rats trBl:ited
neonatally with MSG. The appa rent Km (mM) a nd veax ( nmo l/mi nl
mg ) of the hepat ic ethylmorphine demethylase (EMOM ) in male
r a t s treated with monosodium glutamate (MSG) (0, 2 o r 4mg / g ,
sc ) o n Day 1 , 3 , 5, 7, & 9 o f li fe, and assayed on Da y 65 .
Dos a ge Km Vmax
( mg / g ) ( mM) ( nmo l/mi n/mg )
0.50 tO .03 8±0.8
0 .46±0 .03 9 ±0 .7
0 .52±0 .0 3 11±0 .3 '
Va lues are ex p ressed as MEAN±SE; one rep U cate i nc u batio n was
per f o rmed for each sample .
·S ignific antly d i fferen t (p<0 .05 ) from o t her doses.
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zer- and 16a-p roducts are indicative o f the 2ell isoform . I t
is clea r that MSG increased the 6B-activi ty but not that o f
the 2a / 16a activit ies (' f ab l e 3-14) . Thu s , it appears that t he
MSG i nc r e a s ed P450 3Al/2 but not zcr i .
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Table 3-14. He pa t i c 68-, 16a- , & Za - t e s t oste r o ne hy d r o xy l a s BB
in 65-Day-old ma l e rats tre a t e d neonatally with MSG. Hepati c
6B-, l6a- , &. la-testosterone hydroxy l a s e activit ies i n na i e
rats treated neonatally with monosodium glutamate (MSG) (0 , 2
or 4mgJg, sc) , on Day 1 , 3 , 5 , 7, & 9 o f life., &. analyzed o n
Day 65 .
Dos a ge •• "0 20( mgJgl (nmol JminJmg) (nmol JminJmg l ( nmo l J min J mg l
0 .36±0.06 0 .53±0 .1 3 0 .5210 . 10
0 .52±0.04t 0 .66±0 .04 0 .60±0 .04
0. 53±0.04t 0 .68±0 .09 0 . 6310 . 03
Values are expressed as MEAN±SE; one rep l icate i nc u ba t i on was
p e r f o rme d for each sample .
tSignificantly different {p< O. 05 1 f r o m cont rols .
••
4.0 DISCUSSION
4 . 1 ADRENERGlC RECEPTORS AND THE DEFEMINIZATION OF EMDM
From our studies, we conclud e t ha t mix ed a l/aradrenergi c
agonist (phentolamine), mixed B-adrenerg ic agon i st
(isoproterenol), ai-adrenergic agonist (phenylephrine 1,
a2-adrenergic agonist ( c l on i d ine) & an tagonist (WY27127) , a t
the dose of 50 ~g (phento lamine given at 25 \1g), do no t
inhibi t defeminization of EMDM , cause significant changes in
the to tal amount of P450, activity of p-NPH or cytochrome c
reductase; that propranolol, a mixed BI/B2-adrenerg ic
antagonist, and prazosin, an a t-adrenergic antagon ist, both
given at the dose of 50 \1g, increased defeminization of EMDM,
and the super-defeminization i ndu c ed by propranolol is not v ia
increasing the activity of. cytochrome c reduc tase, the tota l
amount of P450, or tihe apparent KIn, but due to the increase of
the apparent Vmax of EMOM . Further, propranolo l
superdefeminizes t he activities of 20-, 16a- , & 6B-
tes toste rone hydroxylases ; but both prazosin and propranolo l ,
given simultaneously a t equal doses of 50 \1g, prevent super -
defemin ization. However, prior to our studies it not
known whether adrenergic receptors are involved j.n the
de feminization or hepatic cytochrome P450 system, and the
mech anism of the action of adrenergic receptors in
de feminization is still not clear.
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4.1.1 Adr e nerq i c Receptor s and e NS Def emi n i z ati on
A large amount o f e v i de nc e ha s shown t.hat ad renerg ic
receptors ar e tnvctved in the defe miniz03tion of t he brain i n
rats. Admi n i strat i on o f ad re ne rg i c drug s t o ne wborn rats
a lte red t hei r s e xu a l f un ct ion, behaviour a nd t he struc tures of
the bre m ( J a r z a b et al., 198 9a,b , 1990a, b ,c ) . Due t o the
fact t ha t s exua l differences i n hepatic cytochromes P450
probabl y resu l t from the brain's sexual different iat ion, we
hypothesised that intervention on the adrenergic system during
the neona tal per iod wou ld al t e r t he s exu a l l y dependen t
cytochr ome P450 in the live r. Our da ta show that neonata l
propranolo l (B-adrenergic antagon i s t ) or prazosi n ( a 1-
adrenergic antagonist l, given intraventricular ly, caused
"supe r -defeminization" of EMDM activity in poatpubertal male
r a ts . These resu l t s suggest that al - and a t least one B-
adrenerq ic receptor are involved i n inhibiting de fem inization
of the hepati c cytoc hromes P450 i n the n orma l rats .
I n our s tudy , stimulation of the B-adrenergic receptor by
isoproterenol (Table 3-3) did not decrease defeminization .
This may reflect t he full oc cupanc y o f inhibitory B-adrenergic
receptors by no repinephrine i n t he physiologica l condition .
On the other hand, i nhib i tin g EI/52 receptors by propranolol
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might simply allow more norepinephr ine to bind to an un know'l
receptor that stimulates de remrruaet ron . Our result is in
agreement with a previous conclus ion r egard i ng the ro le of n-
adrenergic receptors (Raum an d Swerdioff I 1981 ; McGivern et
al. , 1986) .
Similarly , the increase o f defe mi n iza t i on by PRA-lnduced
i n h i b i ti on of the al -adrenerqic receptor (Table 3-3) indicates
t ha t the ai - adrenerg ic receptor is i nvo lved i n the
de feminization a nd that a i-adrene rgi c agonist (n o r epinephrine)
co mpl ex unde r physiologica l condi tion inhibi t s the
de f e mi nization of hepati c cytoc hrome P4 50. Al t hough
phenyleph r ine (a s pe cific ai-adrenergic agonistj (Tab le 3-3)
given neonatal l y did no t decrease the defeminlzation of EMDM ,
i t doe s no t e x clude the possib ili ty that an a i-adrenergic
rec eptor-compl ex may cause t he defemi ni z i ng process of he pat ic
cyto chrome P450 . Th e lack of a r esponse to the ago nist may
re sult f r om f u lly occu p i e d a t-ad r en erg i c r e c e p t or s unde r
normal phys iologica l cond i tions . Also only one dose of
a goni s t was used. Our da ta that propranolol a nd pra zosin
together suppressed s up erde fem in i za t i o n suggest that both two
d r ug s i nhibit e a c h athe r .
Previous report s showed that perinatal stimul ation o r
inhibition of e NS a d r en e rgi c activity af fe c t e d the contro l of
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gonadotrop ic secretion and sexual behav iou r . I t appears that
the roles of the dif ferent t ype s of adrenergic receptors i n
the modulation of these defeminizations a re different .
Stimulation of the a ··adrenergic r e c e pt o r during the
neonatal pe r iod prevents the defeminizing effect o f neonatal
testos terone in female rats (Raum and swerc nce r , 1981), which
pre ve nt s t he oc currence of a cyclic gonadotropin secretion and
leads t o anovu lation, interrupts the vag i na l cyclicity and
suppresses t he lordosis ref lex, a be hav iour of adult female
r ats responding to t he moun t ing a ttempts of a sexually ac tive
ma l e by an arching of t he back. Thei r da t a suggested t hat
activation of t he 13-adrenergic receptor i nhi b i ts
defeminization . Othe r evidence a lso supports this hypothesis .
Prenatal stress nee been demonstrated to cause a smal l r i s e in
catecholamine leve ls i n the dam , but a 3- to 4- fo ld rise i n
the f e t u s ( Rohde et a l ., 1983 ) . Thus, the development of
female patterns of saccharin pre f ere nce and maze lear ning
behaviour is thought to r e s ul t from the prenatal s t ress-
induced i ncr e as e in nor e p inep hr i ne . It wa s reported (McGivern
et a l. , 1986) t ha t propranolol prevented this development of
f emale patterns of saccharin preference a nd maze learning
behaviour in adult male r ats. Furthermore, since androge n is
converted t o estradiol, whi ch acts to defeminize the brain,
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v ia a romatization and B-adrenergic antagoni s t pr ev e nts the
i nhibi t ion o f nu clear e s tradio l ac c umu r e t i on p r oduc ed by n-
adrenergic ag onist ( Raum et a1., 1984), i t i s hyp othesized
t ha t the inhibition of defem i n i z ing e f fec ts ma y be medLa t ad
v ia s t i mul ating t he B-adrenergic receptor (Ra um e t a 1 . , 1984 ) .
In contrast , the ai-adrenergi c r e c e pto r seems t o play
another ro le in the de feminiza t ion of gonadot ropin s ec r etion.
It was found that prazosin , an a i-adrenergi c an tagon i st,
prevented the reduction o f lordosis behav iour i nduce d by
neonatal testosterone i n female rats (Ja rzab u t; a L. , 198 7 ),
indicating that ac tivation of the a I-adrenerg i c rece ptor
stimulates defemin ization . They suggested that blo c ka de o f
the al-adrenergic receptor allows more norepinephrine t o bind
to the l3-adrenergic r e c e pt o r and inhibits defeminization.
Besides , Raum and his colleagues (1984 ) reported that
phenoxYhenzamine, an a-adrenergic antagonJst, inhibited the
nuclear accumulation of estradiol converted from androgen
(Raum et a L, , 1984); thus, blockade of the a -adrenergic
receptor al lowed less estradiol to defeminize the br a in .
The uZ-a drenergic agonist , c lonidine, also attenuated the
inhib itory effect of neonatal testosterone the
d ifferentiat i on of l o r do s i s behaviour i n f ema l e rats (J;u: za b
9 2
et a l ., 19 87 } . J arzab a nd his colleagues h y pothes i ze d t h a t
pre s y nap t i c s timulation of the Qradr e nergic receptor re duces
t he releas e of norepinephri ne i nto the s y naptic c left a nd
lead s t o l ess stimu l ation of postsyn ap tic QI- and B-adr en e r gic
receptors, and attenua t es t h e defemini zing e f f ect of ne on a tal
t e s tosterone.
Briefly, t he a u t hors a bove hypo the s ized that the
defeminizing a r recrs o f po s t na t ally a cting s teroids may be
mediated vi a s t imu l a t i ng the a i-adrenerg i c (postsyn aptic)
r e cept or , and t hat b loc ka de of d efemin ization may be mediate d
v ia stimula ting the a- adrener gi c recepto r, a nd acti va tion of
t he Q2-adre nerg i c r ecep t o r may i ndi r e ctly i nhi b it
defe min iza t ion act ivity via the B- a d rene r gic recep tor.
Howev er, th i s mode l can no t fully ex pla in all results
avai lable, for e xa mple , act iva t i o n o r inh ibit i on of 13-
adrener g i c rec ep t ors du ring pos t na tal devel opment pe r manen tly
i mpai r e d t he responsivenes s of the ce n t re f or cyclic
gonadotr op in re l e ase to gonadal steroids in f ema l e rats
(Jarzllb e t al . , 1989a ) , and mi g h t not be true for the s exual l y
diffe rentiated hepat ic cyto c h r o me P4 50 s ystem. Rezni ko v e t
al . ( 199 0 ) s howe d t hat t ropo I one , wh ich i nhihi t s ca t echol-o-
methyl t r ans feras e so t ha t no r e p i ne ph rine i n c reas es in the
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hypothalamic sy naptic c lefts a ugmen t e d t he s terilizing effect
o f neonatal tes tosterone on fema l e rats . However, th is s t udy
tells nothi ng o f receptor type invo lved bu t on ly t hat i ncrease
of n o r ep i neph r i n e stimulates defe minization . I n ou r study
(Ta b l e 3 - 3 ) , both n eo na tal proprano l ol (l3-adr e nergic
anta g on i s t ) and n e on a t a l p r azosin (ai- adrene r gi c a ntago nist)
stimulated the defeminhation of hepa t i c EMDM ; t hese data
su ggest t hat bot h a l- a nd a-ad rene r gic re c e pt or s
i nh ibito r y t o the de f e mi niza t i on o f hepa tic cy t o c hr ome P450
under physiological cond i tion .
Our c o nc l us i o n a bou t t he ro l e o f a - adrene rgic receptors
i n defemi n ization is agreement with J a r zab e t a l . 's
hypothe s i s . However , our co n clus ion co n cerning t he r o l e of
a I- a drene rg i c r eceptors i n de feminization i s co n t r adictory t o
t ha t of the a bov e researchers (eg. Jarzab et a l., 1986, 19 87 ) .
That s timu l a tion of t he a i-adrene r gic r ec ep t or i nhibits
defe mi nizat ion is concluded f r om our data ; bu t a n o p posing
role of aj- a drenergic rec eptor is dedu c ted f r om their results .
One e x plan a tion for th i s d iscrepancy mi g ht be tha t
different parameters we r e used to me a sure d e femin i za tion ( e g .
repr oductive endocrine s tat us a nd behav i o u r vs . cytoc h r ome
P45 0 ) . It ha s b e e n r eported ( J a rzab et al. , 198 9a) tha t
9.
stimulation o f t he B-adrenergic receptor dur ing the perinata l
p eriod i ntens i f ied differentiation o f fem i nine reproduct i ve
be haviour but impaired d iffe r e n tiatio n o f feminine
gonadotropin secretion. Thus, p r a z o sin , an a;-adrenergic
antagonist, attenuated the inhibitory effect of neonata l
testosterone on the differentiat ion o f lordosis behaviour in
female rats but failed to prevent t h e a novulato ry s yn d rome
inrluced by neonatal testosterone ( J a r z a b et a l ., 198 7) . These
studies indicate that di f f e r e ntia t i o n o f different sexual
functions may not overlay i dentical adrenergic mechanisms, and
imply the possibility that d i fferent systems mig h t be
differently effected .
It was reported that st imulation of the a z-adrenerg ic
receptor by clonidine attenuated the r eduction of lordosis
capaci ty , induced by postnatal treatment of female r a t s with
t e s t o s t erone ( J a r z a b e t al ., 1986). The au thors hypothesized
that presynaptic stimulation of the Qradrenergic receptor
decreases the release of norepinephrine into the synaptic
cleft and l e a d s to less st imu lation of postsynaptic Qj- and B-
adrenergic receptors . However, this speculati on contradicts
our clonidine data in which clonidine did not change
defemin i zation . In our s t udy , the prevention of propranolo l -
induced "s upe r - de f e mi n i za t i on" by prazesin , a very pot e n t and
selective a I-adrenergic antagonist , s ugge s ts that
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norepinephrine might bind t o the ai -adrenergic receptor, when
both a l- and B-adrenergic receptors a re blocked, so that the
a2-adrenergic-agonist (norep inephrine) complex prevents
"super-defeminization". Our data on p hento lamine are
consistent with this . Phento lamine blocks both a , a nd al -
adrenergic receptors, and the "s u pe r - de f e mi n i zat i on " ca us e d by
propranolol is not "affected . That ne ithe r clonidine (aZ-
ad rene rgi c agonist ) nor WY27127 (aI-adrenergic antagonist)
inf luenced PRO-induced "super-defeminization " implies that the
a z-adrenergic receptor under physiological condition might be
of minor importance in t he defeminization of he p a ti c
cytochrome P450 , but it mig ht repl a ce t he i nhibitory ro le of
both a1- and B- a dr e ne rg i c r e ceptor s und er some circumstance.
4 .1.2 MechlUlism of the Action of Adrenergic Receptors in
Defeminization
Defemi ni zation is i nduced by neonatal s ex steroids .
Under the i nf luence of neonatal a nd ad u lt sex.ual steroids, the
morph olog y and t he neur otransmi s s i on o f the brain de velop in
s e xua lly di fferen t ways; consequent l y, reproductive hormone
a nd be h a v i ou r , and other brain-controlled phys i o l og i ca l
f unct i on s s uch as the secretory pattern of GH a re s exuall y
dif f erent i ate d.
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During t he ne on a t al pe riod a nd r ogen i n the br a in i s
co nverted t o est r ad i o l v i a aromat izat ion. Es trad i o l then
binds to estrogen r ec e p t or s in cytosol and t he complex enters
the nuc l e u s and presumably combines wi th the ge nes whi ch
r e g ulate defemini za t ion. The essential rule of es trad i ol i n
defeminization has been confirmed by McCart hy et a l. ( 19 93 ) .
They i nf u s ed a I S-mer an tisense oligodeoxynu c leotide to the
trans l at ion s tar t codo n of e s t r oge n receptor messenge r RNA
into the hypothalamus of rat pups. and found protect i on
agains t many of the defeminizing effects of testosterone.
Although i t i s known that adrenerg ic recept ors modulate
t he defemin i z ing effect of neonata l testosterone , the
mechanism of the action of adrenergi c receptors on the
defemin ization is not known . That t ropo lone a lone did no t
defeminize fema le rats but augmented the steriliz in g ef f e c t of
neonatal testosterone on fe male rats ( Re zn i ko..... ee a l. 19 90)
and that neither phen tolamine nor isoproterenol ( '1'able 3-1)
t ncce eeec the activ i ty of EMDM in male rats castrated
neonatally suggest adrenergic receptors modulate but do no t
mediate the defemi niZing effect of neonatal androgen .
Raum et a l . (1984) sh owed that t he nuclear estradiol in
hyp othalamus was de creased in rats treated with a -adrenergic
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agonists and that both exogenous t estosterone a nd a-edr eo ererc
arrt a qc n ds t.s prevented the decrease . They suggested,
therefore, that s timulat ion o f n-edcenerc rc r e c e pt o r s
de cre as es the act ivity of aromatase and reduces the
a ramatization of /Io 4-androgens. Howeve r, ev i dence in<!icates
t ha t the a r oma t a s e is activated by phosphoryla tion (eg. B-
ad renergic act i v ation) . It has b e en de monst r a t ed that the
ac tiv i ty of aromatase was decrease d when a lkaline phosphatase
was added to t he buffer and wa s stabiliz ed by ph os phate buffer
or phos p ha t ase i nhibitors (Be l lino a nd Holben , 1989 ).
Further, i t i s know n ( Lefk:>wi t z at a l . , 1990) t hat stimulation
o f the n-adrenergic r ece pt or activates , un de r t he i nf l ue nce of
a st imulatory guanine nucle o t i de-b i nd i ng regulatory p r o t e i n
eGa) ' aden ylyl cyclase , wh i c h promotes t he accumulation of
cAMP, at the cy top la£:nic face of t he plasma membr a ne . cAMP
the n ac tivates cAMP- dependent prote in kinase i n cyt os o L The
activated cAl"lP- d ependent p rotein kinase (protein kinase A)
catalyzes t he p ho sphory lation of ph ospho r y las e kinas e , thereby
a ctivat i ng it . Phospho rylas e kina s e t hen pho s pho ryla tes a nd
activates phospho ry lase which phosphorylates a var i e t y of
ce l lular p r oteins and regula t es the i r activities . The refo re,
Raum's theory i s inconsistent with t hese facts, a nd t he
p revention o f de f eminizati :)n by s timulat ing t he a-adrenergic
receptor do es probably no t occur via the a r omatase . On t he
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othe r hand, it has been repor t e d t hat inc reasing cellular cAMP
markedly decreased e strogen binding t o the nuc l e ar receptor
(Ped e r s e n e t al. , 1991) . Thus, it seems that the pr eventi on
o f defeminiza t ion by a -adrenergic agonists might occu r vi a a
de crease in estrogen binding to t he nucle ar r e ceptor or t he
genome . However , although there were repor ts t ha t
phosphorylation participates in the transcription regu lation
by estrogen receptor complex (Ishibe, 19 93; Ali et a l. , 1993 )
and that phosphorylation of estrogen receptor increased the
affinity o f es t rogen receptor for specific DNA s e quences
(Den t on e t a L. , 1992), i t seems t ha t e s t rogen re ceptor has
autophosphorylation activity, Le , the estrogen receptor can be
phosphorylated with ATP without any protein kinase ( I shi be ,
1993 ) . Thus , whether the increase of cAMP induced by t he
act i vation o f adrenergic receptors is necessary for the
phosphorylation of estrogen receptors is not known . Further,
it was suggested that an increase i n overall estrogen receptor
phosphorylation doe!' not necessarily result in the increase of
transcriptional activity (Aronica and Katzenellenbogen, 1993 );
that the modulation of defeminization by adrenergic receptors
is vi a regulating the estrogen behaviour is still discussable .
Therefore , as functions o f receptors that are regulated by
phosphorylation are on ly beginning to be investigated, more
studies are needed t o solve the problems co ncerning the
99
rel a tionship between es t ro ge n r eceptor an d phosphor ylation,
and a l s o the mys tery r egard i ng t he mec han ism of ad renergi c
receptor act ion i n de fe minization .
Stimulation o f the a i-adrenerg i c r e c eptor leads t o the
activat ion of a membrane-bound phospholipase C which
hydrolyses a membrane phospholipid to f orm diacylglycerol
(DAG) and Inos t t ol-1, 4, 5- t r i s phos p ha t e ( I P)) . I P) then causes
the r e l e a s e of calt f r om intracellular s to r e s , which in i ti a t e s
a varie ty of ce l lu l a r r e s pons e s ; and DAG stimulat e s the
activity of a Cah -sensitive enzyme, protein kina se C, whi ch
phosphory lates a distinct s e t of substrates ( Lefkowitz et al .,
1990) includ ing some substrat es a lso for protein ki na s e A. I t
ha s been four.d (P e t i tti and Rtgen, 19 91 ) that s timul a t i o n o f
the a j-ad r energic receptor enhanced 13 -adrenoceptor-s t imulated
cAMP fo r matio n in r at hypothalamus , and protein kina se C
ap peared to med iate t his pr o c e s s . Thus, stimulat ion of EMDM
defeminization by prazosin does not seem to be r ela t e d to the
arometeee . Since stimulat ion of the ai-ad renergi c receptor
appears to intens ify the B-adrenoceptor-induced cAMP increase
which will decrease estrogen binding to nu clear receptors , t he
inhibition at' de feminization by the a j-adrenerg i c agonist
comp lex might o ccur via cAMP increase . Howeve r, since s o me
substrates phosphorylated by protein kinase C are different
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from t he s ubstrates phosphorylated by both protein kinases C
and A, it imp lies that the ai -adrenergic receptor a ct
diffe rentl y from the B-adrenergic receptor. I n our data, the
to tal amoun t of cytochrome P450 was increased by propranolol
bu t not by prazosin in the s uperdefeminized animals and this
suggests t hat t he a I-adrenergic re ceptor in de fe min ization
might a c t in a way comp l et e l y i nde pende n t of the a-adrenergic
receptor .
There is evidence showing that alterat ion of
c a t e cho l amine transmission during the brain development causes
long-term cha nge s in neuronal organizat ion . For e xample,
prenatal exposure of rats to the dopamine (~A) antagonist
haloperidol induces a long-term decrease in DA receptor number
in the brain (Rosengarten and Friedhoff , 1979 ). Neonatal
c lonidine treatment causes l ong- t e r m changes i n noradrenaline
s e ns itiv i t y ( Gorter et al ., 1989) .
Adrenergic receptors might generate the formation of
c e l l u l a r cAMP, stimulate phosphorylation, and activate protein
kinases and s rm.i.Lar Ly stimulate the neuronal development.
Stimulation o f the QZ-adrenergic receptor i nh i bits adenylyl
cyclase ; as a consequence , intracellular concentration of cAMP
are lowered and the activity of cAMP-dependent protein kinase
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i s decrease (Le fk owi tz et a I. , 19901 . The refore , blockade o f
both Q1- and a -adr energic receptors allows eo r e no rep inephr ine
bind to the Qradrene rg ic recepto r . The act ivati on of Q:-
adrenerg i c recept ors d ec r e a s es i n t r ace l l u l ar concentrat ions o f
cAMP and l ea ds t o the de p ho s pho ry l ation of c ellular pr o t e i n .
Thus , t he activi ty of aromatase lIi gh t be l owe r ed and the
de fem i n ization lIight be inh ibited . In another way, ac t ivat ion
of t he pr es yn a pti c Qr adre nergi c recepto r inhibit the re reese
o f norepi neph r in e a nd l e ad s t o l e s s stimulation of t he
s t i mu l a t or y r ec eptor for the de femi n ization o f hepa ti c
cytoc h rome P45 0 .
Howeve r , the ro l e o f t he B- a dr e n e r gic r e c e pt o r i n t nee e
p rocesses i s p r obably different f r a il that of the a i-adrenerg i c
r e cepto r . Thus , activa tion of the B-adrenergic recept o r
s ti.ula tes mainly a denylate cy clase , bu t t he a i- adrenerg i c
e e cepece i s mainly responsible for t he regulation of prote in
kinase C a nd Ca2f /calmodulin-sensitive protet.l ki nases .
Furt he rmo re , t he 8-adrene r g ic receptor i s ab le to regulate the
activi t y of o r n i t h i ne decarbo xylase, which is i nvo lved in t he
processes of axa genesis and synaptogenesis (Morris and
S latkin , 1985; Slat k in an d Ba r t ha l ome , 198 6; Slat k i n at a l .,
1 988) ; ttcweva r , no data i ndi ca t e t h a t t he at -adren erg i c
recepto r i s related to t he r equ l atian a f t his e n zyme .
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The r efore, the I)-ad r energic re ce ptor mi gh t ha ve different
app roach (ee ) to modulate the defeminization from th at of t he
aI-adrener gic receptor.
Although alteration of some catecholamine transmiss io n
wi t h dopamine (CA) ant a g oni s t or c l on i d i n e duri ng the brai n
dev e lopment cau s ed l ong- t erm chan ges i n ne ura l organization
such as c hanges i n CA receptor n umber and norad r enaline
se ns i tivity of the brain (Rosengarten and Friedhoff, 1979 ;
Gorter et al., 1989), c hanges of B-adrene rgic activi ty do no t
seem t o have l ong- t erm eff ec t on noradrenergic s ystem of t h e
rat b r a in (Erdtsieck-Er nste et aI. , 1993) . Pos t natal b lockade
of t he B-adrenergic r ece pt o r with labeta lal , a n aj- an d B-
adrenergic an tagonist , i ncreas ed aI -adrener g ic recepto r
bi ndingj however, ne ither propranolol no r 1abeta lal ha d l ong -
term effect on the B-adrenoceptor number in the mature rat
brain. Al though postn a ta l propranolol c aused a n i mmediate
incr ease of norad re na l ine ( NA) metabo l i s m, the long -term
effect of this d ru g on NA metabolism is still q uestionable .
The r e f or e , the B- adr energic recept or mi g ht ha v e i mmediate
ef f e c t on the action o f neona tal and r oge n, which defeminizes
the b r ain s t r uc t u r e and some neurotransmi t te r syst ems which
ar e r e l a t ed t o t he sec r e tion of GH. However , s i nce t he da t a
conce rn ing t he long-te r m effect of B-adrenocepto r agents on B-
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a dr enccept.oz- number and NA metabolism were o bt a i ne d based on
the usage o f no n - select i ve B-adrenerg i c agen t s, further
studies are s t i ll needed t o con fi rm t he conclus ion.
Furthermore, the evidence above does not ex c l ude the lo ng- t erm
e ffect of Ql- and a2- ad r e ner g ic recept or s on ad r-enoc ep tor
number and NA metabolism .
4. 1.3 Kinetics of EMDM and 16a- , 2a- , and 6B-Testcst ercne
Hydr oxylas es in PRO- induced Supe rdef eminizatic n
Since a drenergic drugs do not result i n s ignif i cant
changes i n the total amount of P450 and the activities of
cytochrome c reductase a nd p-ni trophenol hydroxylase , the
final effect i ndu ced by adrenergic agents the
defemlnization o f EMDM impacts on t he i soforms of sex -
dependent cytochrome P450. Although propranolol increased the
t ot a l amount of P450 , the increase was not significant and i s
u nexpla i nab l e to t he marked elevation of EMDt-1 activity .
P r opr a nol ol did not cha nge the apparent Km o f EMDM but di d
increase the apparent Vrnax in the superdefeminized group;
t her efo r e , the enhancement of EMDMactivity by prop ranolol is
due to the increase of Vrnax . Since the alteration of activity
or amount o f the isoform(s ) demethylating ethylmorphine
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resu l t in ch a nges i n the Vmax o f EMDM, i n c r eas e of EMDM
activi ty by p r oprano lol migh t be re la ted to a r ise in t he
ac t ivity or amoun t of i s oform{s ) r esponsible for e thylmorphine
deme thyla t i on .
Cytochrome P450 2C11, a maj or male-specific P450 , 1s
respons ible fo r 15a - and 2a -testosterone hydroxy lations ( Kato
et al. , 1 98 6 ) and cyt o c hrome P450 3A1{2, another male-specific
i s o f or m, ca ta lyses 613-testosterone hyd r oxyl a tion (Imaoka et
al . , 198 8) and is a l so a major isoform for ethylmorphine
de me t hy l a tion (Wri gh t on et al. , 1985). In our study,
propranolol increased t he activi ties of 53 - , 16a- , and zc -
tes tosterone hydroxylases; therefore, propranolol stimulated
t he de femini zation o f hepatic cytochrome P4 l:iO by i ncreas ing
t h e expression of at l e as t two isaforms 2C11 and 3A1/2 .
It h a s been re ported neonata l defe mi nization i nd u ced high
amp l itude GH pulses ( J ans s o n an d Frohman , 19 87) , wh i c h i s
paralle l t o the defemi nization of EMDM activity (Virgo, 199 1) ,
in adulthood . Furthe rmore, bot h neonatal de feminization and
ad u lt masculinization together lead to typical mas cu line
pattern of GH secretion (Jansson and Frohman , 1987 ), whi c h i s
parallel t o the pub e r t a l activi ty of EMOM (Virgo , 1991 ) .
Besides, it was found that decline i n the ampl itude o f GH
105
pulses with intact: ultradian rhythm caused 16a-, 2a-, and 613-
testosterone hydroxy lases, and isoforms of P450 2e l1 and 3A2
to exceed normal levels (Shapiro et al ., 1989; Pampor i et; a.l . ,
19 91 ) . These data suggest that the secretory pattern of GH
d etermines the exp ression of some sex-dependent cytoch rom es
P450, and that a.lteration of GH secretion mi ght change the
activities of these rsc rcms . Therefore, the
s u perdefeminiz ing e ffect of propranolo l on the activities of
16a-, 2a- , and 63- testosterone hydroxylases might be via
a 1 tering the secretory pattern of GH, which in turn s timulates
the expression of sex-dependent P450 isoforms , in adulthood .
4 .2 NEONATAL MONOSODIUM GLUTAMATE AND PREPUBERTA L DEVELOPMENT
OF MALE SPECIFIC CYTOCHROMES P450
From ou r data, we conc l ude that neonatally administe r ed
monosod ium g lutamate (MSG) does not affec t the activi ties o f
hepa ti c EMDM, p- NPH or cytochrome c r e duc t as e , or the total
amount of cytochrome P4 50 in 35 day old {p r e -epub e r t a L} rats.
Fu rthermore, p-NPH activi ty reaches adult levels before
pu b erty. However, n e onata l MSG i ncreased EMDM activi ty
between day 35 an d 65 (post-pUberty) while p -NPH and
c y tochrome c reductase activity we re not altered. Th e tota l
amount of cytochrome P450 was increased by 26% in the
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post pubertal rats g i ve n ne onatally 4 mg/g MSG. Neonatal 2
mgjg or 4 mg/g MSG di d not change the apparent Km o f EMDM
activity in the pos tpubertal rat liver, but 4 mg /g MSG
increased t he apparent vmax by 38%. Further, neonatal MSG
i nc r ea s e d t he act iv i ty of 6B- bu t no t 2a /16a-testosterone
hydroxylases i n the r a t liver at Day 65 .
4 .2 . 1 Prepuber t a l Development
Neonatal administrat ion of monosodium glutamate ( MSG) to
rats produces almost c omple t e disappearance of CH releasing
hormone (GHRH) immunoreactive cell bodies in the ar cuate
nu c leus and C::nH-immunoreactive fibres in the median eminence
( Olne y , 1981 ; Lemkey-Johnsto n and Reynolds, 19 7 4) , while
apparently having no effect on adjacent areas i n the
hypothalamus. Consequently, serum concentrations of GH ( Te r r y
et a L, , 198 1 ; Nemeroff et a l. , 1977) are profoundly reduced ;
whe reas serum levels of ACTH ( Kr i e ge r e t aI., 19 79 ) , PRL
(Terry e t a l ., 1981 ) , T5H ( Ne me r o f f e t al., 1977), F5H, a nd LH
(Dada and Blake, 19 85 ) are normal. Therefore, we adm inistered
MSG to male pu p s t o e liminate plasma GH and observed the
r e l at i on s h i p between GH and the development o f hepatic
cytochrome P45 0 .
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It is well known that the activity of sex-dependent
cytochrome P450 in rat liver displays developmental changes.
The act ivity of hepatic EMDM in male rats is low during the
neonatal period, but begins to rise gradually at 4th week and
reaches adult l e v e l s at or after puberty (Gram et al., 1969) .
Cytochrome P45 0 2CIl , a male specific isoform, i s undetectable
in male pups; it then expresses a gradual increase of activity
to the 4th week, and shows high adult act ivity at puberty
(Waxman et al ., 1985; Imaoka et al., 199 1). Cytochrome 3Al/2,
other male specific isoforms, also displays deve lopmental
expression . In contrast to the increase of 2Cll isaform in
male r ats , it is mainly a-tpp r eaaed in female rats (Waxman e t;
aI., 1985; Imaoka et al., 1991). All the activities of EMDM
(Colby, 1980 ), 2C11 (Mode et a I., 1989; Legraverend et a L, ,
1992) and 3A1 j2 (Waxman et a1., 1988) are regulated by GH at
adu Lthood . The secretory pattern of GH was demonstrated to
determine the expression of male specific isoforms 2el1 and
2C12 ( Mo de et al., 1989; Legraverend et al., 1992). Male-type
of GH secretion stimulates the expression of the male isoform
2Cll, but suppresses the appearance of the female isoform
2C12; while female pattern of GH secretion suppresses the
expression of 2Cl 1 isoform, but promotes the 2C12 expression.
Although the expression of isoform 3A1/2 is not dependent on
pulsati Le plasma GH (Waxman et al ., 1988) , its expression is
s uppressed by GH (Waxman et al . , 1988) .
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Our data ( Ta b l e 3-9) show that neonatal admin istration o f
2 or 4mg/9 11SG did not ch a ng e t he activity of hepati c EMDM i n
35 -day old rats . S ince it was reported (Shapiro et al . , 1989;
Wax ma n et aL, 1990 ) t ha t 2mgj g MSG caused an 80 -90% reduct ion
in the pulse amplitudes of plasma GH a nd 4mg j g MSG resulted i n
t he total l oss o f all measurab le l e ve ls o f c i r c u latin g GH i n
adulthood , an d further, that plasma GH i n prepubertal rats i s
undetectable (Khorram e t al ., 1983; Strasser and Mialhe ,
1975 ); therefore , in t h i s study, t.ne.re should be no plasma GH
during the prepubertal period . Thus t he data s uggest t ha t t he
prepubertal development o f the male t ype P450 in the rat liver
is no t r ela t e d to p lasma GH. Further , since the r e 1s no
significant diffe rence in the total amount o f cytochrome P450,
the activities of cytochrome c redu ctase and p-nitropheno1
hy d roxylase, 1t seems that GH is not related to the
prepubertal deve lopmen t of hepa tic cytochrome P450 system .
Since the hepatic EMDM activity in male rats at Day 35 is
significantly h i g her tha n that of de feminized r ats , t h e EMDM
activity does exp r e s s a deve lopmental increase. As GH does
not seem to be involved i n t he prepuberta l de velopment of EMDM
activity , t he r e may be other hormones responsible for this
EMDM development .
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Serum corticosterone in rats shows developmental changes
(Lu et a1 ., 1987; Henning, 1978) . During the neonatal period ,
the concentration of plasma corticosterone is quite low . It
increases gradually and reaches the highest point at the 24th
Day but then declines. I t was reported that this hormone
increased the activity of hepatic ethylmorphine demethylase in
adul t rats (Colby, 1980) , and that dexamethasone elevated the
amount of hepatic cytochrome P450 3A (Gonzalez et al., 1986;
Wrighton et al. , 1985; Nagata at al. , 1990), which is
associated with ethylmorphine demethy lation (Wrighton et e L, ,
1985). The concentration of plasma FSH in male rats also
displays developmental changes (Ketalslegers a t a l., 1978) .
At birth, plasma FSH shows high levels but declines to its
lowest levels in the second week; it then cl imbs gradually and
reaches the highest concentration at the 40th Day . This
hormone was reported to be ab le to increase the rate of EMDI'!
in castrated rats of either sex (Krammer et al ., 1977) ,
suggesting that the increase of hepatic EMOM activity induced
by FSH may not via the FSH-stimulated re lease of testosterone .
Thus the prepubertal development of EMOM activity might
reflect the combined effect of enese hormones. However,
plasma testosterone begins to rise at the 4th week of life in
male rats; further, androgen receptors have been found in the
rat liver (Eagon at a1 ., 1989; Konop1ya and Popoff, 1992), the
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poss ib ili ty t hat p r epube rtal d e v e l opment of h e pa tic EMDM
activ i ty resu l t f r om t he g r a du a l i n c r e ase o f p lasma an d r o g e n
before pube r ty ( Co r p e c hot et a l. , 198 1) should not b e
excluded .
4 .2 .2 Pub ertal Development
Since the s ecr e t ory pattern o f GH i s i mportan t to the
activities o f sex-dependent P45 0 isoforms in ad ulthood ,
neonatal MSG wh i c h can e limin ate plasma GH will change t h e
a ct i vity of sex-dependent cytochrome P4 50 in adul thood . Our
data (Table 3-11) show that neonatal ad mi nistration of 2 or
4mg {g MSG increased t he EMDM a ctivity in adulthood . Since
hypophysectomy i ncre a sed the EMDM ac t ivity ( Co l b y , 198 0 ) and
GH t og e t h e r wi th decreased t h e EMDM activ ity in the thyroxine
( T4 ) - , J4.CTH-. o r T4- and ACTH- treated hypophysectomized ma le
rats ( Colb y , 19 80 ) ; and further , c lonidine whi ch i n c r e a s e s GH
release i nhib i t e d EMDM a c ti v i ty , but somatos tat in whi ch l owers
the trough of GH secretion pattern decreases GH r elease
s timulated EMDM activity (Virgo , 198 5 ) , GH is thought to be
inhibitory t o the EMDM a ctivity (Vi r go , 19 85 ) . The refore, the
increase of EMDM activity in MSG- treated groups suggest tha t
neonata l MSG r e d u c e s plasma GH and lessens the suppression by
GH on EMDM a c tivity .
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I n our study , MSG a t dose o f 4l1l9 / g enhanced the a ppa r e n t
Vmax of hepat ic £MOM but did not affect the appar en t Km. Th~
increase of the Vma x of £MOM might resul t from an e leva ti o n 1n
t he a ctivity o r the amount of isofo rm(s) f o r e thylmorph ine
d eme thy lation. sU9Qesting that the i nc r e ase of EMDM activ ity
i nduce d by neonata l MSG is due to an increase of t he activi ty
or amount of EMDM. MSG a t dose o f 4mg/g i ncreased the tota i
amount of cytochrome P450 by 24%. whic h mig h t resul t from an
increase in the amount of i s of o rm(s) and may partly expla in
the c ha nges in EMDM activity .
Micros oma l ac tivi ties of 6B-tes t oste rone hydroxylase. i n
2 or 4 mg/ g MSG-treated r a ts , r os e by 44\ -47% ( Table 3 ~ 1 41 ;
howe ver, MSG d id no t effe c t on the ac tiviti e s o f 160 - and zc-
testost e rone h yd r ox ylases . aeceus e c y tot"hrome P4S0 311 /2 is
res pons i b l e r o r 58 - testost e rone hydrox y l a tion t reeoke et a l .,
1988), and cy tochrome P450 2e U fo r 16 0- an d 2a -testosterone
hydroxyla tions, t he data i mply t hat n e o na t a l MSG influences
t he expres s ion of c y tochrome P45 0 3Al /2 bu t not c ytoc h r ome
P45 0 Zell . EMDM i s ma i n l y a s s ociated wi t h 3Al /2 isof o r m
(Wr ightoD e t a l . , 19 65); t herefo r e, t he i n c r ea s e of EMDM
acti vi ty i n MSG-treated groups i s du e to the elevat ion o f
3Al/2 amount .
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However , our suggestion d if f ers f r om the observation of
Pampo r i an d h is colleagues ( 199 1 ). They showed that t he
neonata l administration o f 2mg/g MSG did not change t he
ultradian patte rn of circulating GH, al though it reduced i n
the pulse amplitudes of plasma GH by 80 %, while it i ncre a s ed
the l e ve l s of cytochrome P450 ZCU and P450 3A1/2 i n mal e
rats . At 4mg/g t he levels of these isoforms we r e depressed .
Concurrently, t he a c tivities of 1613-, 20:- , and 613-testosterone
hydro xy l a s es inc reased o r decreased in pa r a lle l with t he
changing leve ls of the-ir subst rate s p e c i f i c isoforms of P450
(Pampor i et al ., 1991) . The expression of cytochrome P4 50
ac i i i s depen:ient on the secre tory pattern of GH (Mode et al . ,
1 989; l..egraverend et a1. , 1992 ), and low peaks of GH with male
secretory pat t ern are sti ll sufficient to stimulate the
exp ress ion of 2Cll isoform (Legraverend et a l . , 199 2) . The
above r e s ea r c he r s ' s tudies su ggest that decreasing plasma GH
wi t hout changing t he male s ecretory pattern of GH may
intensify the e xpress ion o f 2Cll isoform and t he a ctivities of
16a- and 2a -testosterone hydroxyla s es . Thus, the data i n our
study that 2 mg/g MSG did not change the act.ivities of 16 a -
a nd 2a-testosterone hydroxy lases might that the dosage of MSG
u s ed did not cause a l ow enough reduction in plasma GH, and
that 4mg/g MSG did not i nfluence the activi ties of the 16a-
and Za -hydroxylases in our study might be r eflect that the
p lasma GH was not totally absent .
113
I n Pampod et a1. ' s study ( 1991), 2mg/q MSG i ncr ea s e d the
a c t iv i t y of 613-testosterone hydroxylase, bu t 4mg/ g MSG
depresse d t he activity . Th e e xpre s s i o n of c y tochrome P4 S0
3Al /2 which cata lyses 66 - h ydroxy las e was de monstrat ed to be
not de pe nd en t on t he secretory pa ttern of GH, bu t depressed by
cont i nuo us GH (Waxma n e t a l. , 198 8 ) . Hypo phys ec tomy i nc r e ased
the levels o f cytochrome P4 50 3A1/2, but i n jec tion o f GH to
these r a ts depres s ed the l e v e l s of t he e nzyme (Waxman e t a L. ,
19 9 0 ) . All these data i mpl y that co ntinuous GH is inhi bi t o ry
t o t he e x press i on of 3A1/ 2 i s o fo rm and the a ctivi t y o f 613-
t e s t oste rone h yd r oxylase .
Our data show that bo th 2 and 4mg / g MSG enhan ced the
activi ty o f en-ueeec e e e rooe hydr oxylas e ( Ta b le 3- 14). Th e
i n c r e a s e of the activity of 6J3-testosterone hydroxylase i n
MSG-treate d rats , the refore , might be due to MSG-induced loss
of plasma GH; tilat 4 mg/9 MSG did not suppress the a ctiv ity of
50-testos te r one h yd r oxylase might be due to the failure o f the
dosage i n thi s study to c omplete ly e liminate plasma GH.
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